<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Cell Infect Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Cell Infect Microbiol</journal-id><journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id><journal-title-group><journal-title>Frontiers in Cellular and Infection Microbiology</journal-title></journal-title-group><issn pub-type="epub">2235-2988</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5461351</article-id><article-id pub-id-type="doi">10.3389/fcimb.2017.00231</article-id><article-categories><subj-group subj-group-type="heading"><subject>Microbiology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>PKC-η-MARCKS Signaling Promotes Intracellular Survival of Unopsonized Burkholderia thailandensis </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Micheva-Viteva</surname><given-names>Sofiya N.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/415038/overview"/></contrib><contrib contrib-type="author"><name><surname>Shou</surname><given-names>Yulin</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ganguly</surname><given-names>Kumkum</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/442541/overview"/></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Terry H.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/405853/overview"/></contrib><contrib contrib-type="author"><name><surname>Hong-Geller</surname><given-names>Elizabeth</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/46486/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Bioscience Division, Los Alamos National Laboratory</institution><country>Los Alamos, NM, United States</country></aff><aff id="aff2"><sup>2</sup><institution>Center for Infectious Disease and Immunity and Department of Internal Medicine, University of New Mexico Health Sciences Center</institution><country>Albuquerque, NM, United States</country></aff><author-notes><fn fn-type="edited-by"><p><text><SENT sid="1" pm="."><plain>Edited by: Mary O'Riordan, University of Michigan, United States </plain></SENT>
</text></p></fn><fn fn-type="edited-by"><p><text><SENT sid="2" pm="."><plain>Reviewed by: Özlem Yilmaz, Medical University of South Carolina, United States; Miguel A. Valvano, Queen's University Belfast, Ireland </plain></SENT>
</text></p></fn><corresp id="fn001">*Correspondence: Elizabeth Hong-Geller <email xlink:type="simple">ehong@lanl.gov</email></corresp></author-notes><pub-date pub-type="epub"><day>07</day><month>6</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>7</volume><elocation-id>231</elocation-id><history><date date-type="received"><day>11</day><month>1</month><year>2017</year></date><date date-type="accepted"><day>17</day><month>5</month><year>2017</year></date></history><permissions><copyright-statement>Copyright © 2017 Micheva-Viteva, Shou, Ganguly, Wu and Hong-Geller.</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Micheva-Viteva, Shou, Ganguly, Wu and Hong-Geller</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p><SecTag type="ABS"><text><SENT sid="4" pm="."><plain>Pathogenic Burkholderia rely on host factors for efficient intracellular replication and are highly refractory to antibiotic treatment. </plain></SENT>
<SENT sid="5" pm="."><plain>To identify host genes that are required by Burkholderia spp. during infection, we performed a RNA interference (RNAi) screen of the human kinome and identified 35 host kinases that facilitated Burkholderia thailandensis intracellular survival in human monocytic THP-1 cells. </plain></SENT>
<SENT sid="6" pm="."><plain>We validated a selection of host kinases using imaging flow cytometry to assess efficiency of B. thailandensis survival in the host upon siRNA-mediated knockdown. </plain></SENT>
<SENT sid="7" pm="."><plain>We focused on the role of the novel protein kinase C isoform, PKC-η, in Burkholderia infection and characterized PKC-η/MARCKS signaling as a key event that promotes the survival of unopsonized B. thailandensis CDC2721121 within host cells. </plain></SENT>
<SENT sid="8" pm="."><plain>While infection of lung epithelial cells with unopsonized Gram-negative bacteria stimulated phosphorylation of Ser175/160 in the MARCKS effector domain, siRNA-mediated knockdown of PKC-η expression reduced the levels of phosphorylated MARCKS by &gt;3-fold in response to infection with Bt CDC2721121. </plain></SENT>
<SENT sid="9" pm="."><plain>We compared the effect of the conventional PKC-α and novel PKC-η isoforms on the growth of B. thailandensis CDC2721121 within monocytic THP-1 cells and found that ≥75% knock-down of PRKCH transcript levels reduced intracellular bacterial load 100% more efficiently when compared to growth in cells siRNA-depleted of the classical PKC-α, suggesting that the PKC-η isoform can specifically mediate Burkholderia intracellular survival. </plain></SENT>
<SENT sid="10" pm="."><plain>Based on imaging studies of intracellular B. thailandensis, we found that PKC-η function stimulates phagocytic pathways that promote B. thailandensis escape into the cytoplasm leading to activation of autophagosome flux. </plain></SENT>
<SENT sid="11" pm="."><plain>Identification of host kinases that are targeted by Burkholderia during infection provides valuable molecular insights in understanding Burkholderia pathogenesis, and ultimately, in designing effective host-targeted therapies against infectious disease caused by intracellular pathogens. </plain></SENT>
</text></SecTag></p></abstract><SecTag type="KEYWORD"><kwd-group><kwd><italic>Burkholderia</italic></kwd><kwd>infection</kwd><kwd>RNA interference</kwd><kwd>autophagy</kwd><kwd>intracellular bacteria</kwd><kwd>protein kinase C</kwd></kwd-group></SecTag><funding-group><award-group><funding-source id="cn001">Defense Threat Reduction Agency<named-content content-type="fundref-id">10.13039/100000774</named-content></funding-source><award-id rid="cn001">CBS.MEDBIO.02.10.LA.016</award-id></award-group></funding-group><counts><fig-count count="7"/><table-count count="1"/><equation-count count="0"/><ref-count count="70"/><page-count count="15"/><word-count count="10691"/></counts></article-meta></front><body><SecTag type="INTRO"><sec sec-type="intro" id="s1"><title><text><SENT sid="12" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="13" pm="."><plain>Intracellular bacteria often defy the traditional pathogen-directed antimicrobial therapies through adaptation mechanisms that co-opt host cell processes in order to maximize infection efficiency. </plain></SENT>
<SENT sid="14" pm="."><plain>Pathogenic Burkholderia species, including B. pseudomallei and B. mallei, the causative agents of human melioidosis and equine glanders, respectively, are intracellular pathogens of particular concern, since infections are highly refractory to a broad spectrum of antibiotics and are associated with a mortality rate of ~50% even with antibiotic treatment (Moore et al., 1999; Wiersinga et al., 2006; Currie et al., 2010; Schweizer, 2012). Burkholderia spp. employ two types of secretion systems, Type III (T3SS) and Type VI (T6SS), consisting of multiple effector proteins that mediate host invasion and intracellular survival, thus enabling Burkholderia avoidance of the host immune responses, resistance to antibiotic treatment, and establishment of latent infections (Stevens et al., 2003; Burtnick et al., 2008, 2009, 2011; Muangsombut et al., 2008; Gong et al., 2011). </plain></SENT>
<SENT sid="15" pm="."><plain>Chronic infections caused by B. pseudomallei are a major challenge to achieving sterile immunity and a contributing factor to disease spread outside of the endemic zone, Southeast Asia and northern Australia (Limmathurotsakul et al., 2016). </plain></SENT>
<SENT sid="16" pm="."><plain>Sporadic infections with B. pseudomallei have been recorded in East Africa, the Caribbean, Central and South America, the Middle East, North America and Western Europe, emphasizing the effect of globalization on emerging infectious diseases (Doker et al., 2014; Benoit et al., 2015; Currie, 2015). </plain></SENT>
</text></p><p><text><SENT sid="17" pm="."><plain>In pursuit of effective treatment of persistent Burkholderia infections, several host transcriptomics studies have been performed to characterize changes in host gene expression in response to Burkholderia infection (Ulett et al., 2005; Chin et al., 2010; Mariappan et al., 2013). </plain></SENT>
<SENT sid="18" pm="."><plain>Host genes that function in apoptosis, immune response, stress response, and cellular metabolism were found to be differentially regulated upon infection. </plain></SENT>
<SENT sid="19" pm="."><plain>Yeast two-hybrid screens of whole human and murine proteome libraries have identified 600 human and 846 murine protein interactions with B. mallei virulence factors, demonstrating high representation of host proteins that function in ubiquitination, phagosome formation, and actin cytoskeleton dynamics (Memisevic et al., 2013, 2015). </plain></SENT>
<SENT sid="20" pm="."><plain>To further characterize host gene function in response to Burkholderia infection, we performed a RNA interference (RNAi) screen of the human kinome to identify host factors that facilitate intracellular survival of Burkholderia thailandensis, a surrogate for the more virulent B. pseudomallei. </plain></SENT>
<SENT sid="21" pm="."><plain>Although ~1,000-fold less lethal than B. pseudomallei in animal models, B. thailandensis nevertheless induces phagocytic mechanisms and exhibits growth kinetics in primary human monocyte-derived dendritic cells similar to B. pseudomallei (Wiersinga et al., 2006; Haraga et al., 2008; Charoensap et al., 2009). </plain></SENT>
<SENT sid="22" pm="."><plain>To validate the results of our RNAi screen, we used the clinical isolate B. thailandensis CDC2721121 previously shown to exhibit phenotypes that resemble pathogenic Burkholderia in cell culture studies (Glass et al., 2006). Bt CDC2721121 has acquired the capsular polysaccharide virulence cluster, and thus exhibits B. pseudomallei-like phenotypes, including colony wrinkling, resistance to human complement binding, and survival within macrophages (Sim et al., 2010). </plain></SENT>
</text></p><p><text><SENT sid="23" pm="."><plain>Our RNAi screen revealed divergent roles for protein kinase C (PKC) isoform functions in promoting intracellular proliferation of B. thailandensis. </plain></SENT>
<SENT sid="24" pm="."><plain>The PKC family comprises at least 10 related lipid-sensitive serine/threonine kinases subdivided into three classes with particular features: (1) the classic PKCs (PKCα, PKCβI, PKCβII, PKCγ), which are Ca2+-dependent and activated by both PS and DAG; (2) the novel PKCs (PKCδ, PKCε, PKCη, PKCμ, PKCθ), which require DAG but not Ca2+; and (3) atypical PKCs (PKCζ, PKCί/λ), which are Ca2+- and DAG-independent (Mochly-Rosen et al., 2012). </plain></SENT>
<SENT sid="25" pm="."><plain>Classical Ca2+-dependent PKC isoforms are known to be key regulators of host innate immunity and phagocytosis of opsonized antigen through the IgG receptors (Breton and Descoteaux, 2000; Underhill and Ozinsky, 2002). </plain></SENT>
<SENT sid="26" pm="."><plain>In our assay we have used unopsonized B. thailandensis as a model of early infection event to study the effect of cellular innate immune responses in the restriction of intracellular bacterial growth. </plain></SENT>
<SENT sid="27" pm="."><plain>We identified the novel PKC-eta isoform, PKCη, as a host factor required for the successful growth of unopsonized B. thailandensis within professional phagocytes and epithelial cells. </plain></SENT>
<SENT sid="28" pm="."><plain>Other RNAi-based screens have previously discovered various novel PKC isoforms to be required for the colonization of epithelial tissue cells by intracellular pathogenic bacteria (Prudencio et al., 2008; Jiwani et al., 2012). </plain></SENT>
<SENT sid="29" pm="."><plain>Similarly, these discovery platforms were infected with unopsonized bacteria. </plain></SENT>
<SENT sid="30" pm="."><plain>We further characterized PKC-η/MARCKS signaling as a key event that promotes uptake of unopsonized B. thailandensis by host cells and demonstrated that opsonization is a key factor that determines receptor usage, triggers differential PKC signaling pathways, and eventually determines intracellular pathogen survival. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec sec-type="materials and methods" id="s2"><title><text><SENT sid="31" pm="."><plain>Materials and methods </plain></SENT>
</text></title><sec><title><text><SENT sid="32" pm="."><plain>Bacterial strains and growth conditions </plain></SENT>
</text></title><p><text><SENT sid="33" pm="."><plain>The following bacterial strains were used in this study: (1) B. thailandensis DW503, a derivative from the environmental B. thailandensis E264 (gift from Dr. Mary Burtnick, University of South Alabama) (Burtnick et al., 2001); (2) B. thailandensis CDC2721121, a clinical isolate obtained from the CDC (Glass et al., 2006); and (3) Yersinia enterocolitica WA (pYV+, ATCC 27729). </plain></SENT>
<SENT sid="34" pm="."><plain>Both Burkholderia strains were grown on LB agar plates at 37°C and stored at 4°C for up to a week or were cultured on LB broth with aeration at 37°C prior to the infection of host cells. </plain></SENT>
<SENT sid="35" pm="."><plain>The B. thailandensis DW503-GFP strain was generated by introduction of the BHR4-GFP plasmid (gift from Dr. M. Burtnick) into bacterial cells via electroporation and selection of clones using LB agar plates containing 50 μg/ml gentamicin. </plain></SENT>
<SENT sid="37" pm="."><plain>For cell infection experiments, Y. enterocolitica WA was grown at 26°C in brain heart infusion (BHI, Difco, Detroit, Mich) broth for 18 h in an orbital shaker at 180 rpm, followed by dilution of the bacterial culture to obtain 0.1 OD660 and additional growth for 2 h at 37°C (100 rpm) to stimulate production of the T3SS. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="38" pm="."><plain>Tissue culture cell growth conditions </plain></SENT>
</text></title><p><text><SENT sid="39" pm="."><plain>THP-1 human monocytes (ATCC TIB-202) were maintained in RPMI-1640 GlutaMax media (Invitrogen, Carlsbad, CA) supplemented with 10% FBS (HyClone, Logan, UT). </plain></SENT>
<SENT sid="40" pm="."><plain>A549 cells (ATCC CCL-185) were cultured in DMEM high glucose medium containing 10% FBS (Invitrogen) at 37°C and 5% CO2. </plain></SENT>
<SENT sid="41" pm="."><plain>The RFP-LC3B stable cell line was generated by transfection of A549 cells with pmRFP-LC3 (Addgene plasmid #21075) (Kimura et al., 2007) and flow cytometry sorting using the BD FACSAria. </plain></SENT>
<SENT sid="42" pm="."><plain>Phorbol 12-myristate 13-acetate (PMA) and mannan from S. cerevisiae were obtained from Sigma-Aldrich (St. Louis, MO). </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="43" pm="."><plain>Validation screen using imaging flow cytometry </plain></SENT>
</text></title><p><text><SENT sid="44" pm="."><plain>We validated host gene function in intracellular bacterial replication using a differential two-step labeling method to distinguish between intracellular and extracellular B. thailandensis. Bt CDC2721121 cells (108) were incubated in 1 ml PBS (pH6) containing 1 μg/ml FITC (green) for 15 min at room temperature, washed four times in 1 ml PBS, and resuspended in LB. </plain></SENT>
<SENT sid="45" pm="."><plain>THP-1 cells were treated with siRNAs as described for the screen and infected with FITC-labeled Bt CDC2721121 at MOI 10, 72 h post-siRNA treatment. </plain></SENT>
<SENT sid="46" pm="."><plain>Growth of extracellular bacteria was suppressed by adding kanamycin (250 μg/ml) 2 h post-infection. </plain></SENT>
<SENT sid="47" pm="."><plain>After another 3 h, the infected THP-1 cells were pelleted at 800 g for 2 min and resuspended in fresh antibiotic-free RPMI/10% FBS. </plain></SENT>
<SENT sid="48" pm="."><plain>THP-1 cells were collected 24 h post-infection, fixed for 20 min in 1% paraformaldehyde, and incubated for 1 h in blocking buffer containing 10% sheep serum and 1% bovine serum albumin (BSA). </plain></SENT>
<SENT sid="49" pm="."><plain>Rabbit anti-B. thailandensis serum (gift of Dr. Paul Brett, University of South Alabama) was then added (1:500 dilution) to the blocking buffer, and cells were incubated for an additional 1 h. </plain></SENT>
<SENT sid="50" pm="."><plain>Following three rounds of washing in PBS, THP-1 cells were incubated for 30 min in PBS containing 1% BSA and PE (red)-conjugated anti-rabbit goat IgG (1:1,000 dilution). </plain></SENT>
<SENT sid="51" pm="."><plain>Thus, extracellular adherent Burkholderia were double-labeled with FITC and PE fluorescence, whereas intracellular bacteria were single-labeled with FITC. </plain></SENT>
<SENT sid="52" pm="."><plain>The labeled THP-1 cells were analyzed using imaging flow cytometry (Amnis ImageStreamX) with the following data collection parameters: slow flow rate, 60 × magnification, and extended depth of field. </plain></SENT>
<SENT sid="53" pm="."><plain>Images were collected from the darkfield, brightfield, FL1 (488ex/560em nm), and FL2 (488ex/595em nm) channels. </plain></SENT>
<SENT sid="54" pm="."><plain>Uninfected THP-1 cells treated with rabbit anti-B. thailandensis sera and PE-conjugated anti-rabbit IgG treatment, and Bt CDC2721121-FITC infected THP-1 cells not treated with PE-conjugated anti-rabbit IgG, served as single color controls to establish compensation that excluded channel cross-talk. </plain></SENT>
<SENT sid="55" pm="."><plain>The IDEAS 5.0 software was used to define the localization of internalized bacteria and to determine the percentage of single vs. double-labeled THP-1 cells. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="56" pm="."><plain>Western blot analysis </plain></SENT>
</text></title><p><text><SENT sid="57" pm="."><plain>THP-1 cells treated with 50 nM siRNA were washed twice with chilled PBS and lysed on ice for 45 min with RIPA Lysis and Extraction Buffer (Thermo Scientific, Grand Island, NY) supplemented with a cocktail of protease and phosphatase inhibitor mixture (Thermo Scientific). </plain></SENT>
<SENT sid="58" pm="."><plain>Lysates were centrifuged (12000 rpm, 15 min), supernatants were collected, and total protein was quantified with the BCA kit (Pierce). </plain></SENT>
<SENT sid="59" pm="."><plain>Equal amounts of protein (10 μg) were run on SDS–PAGE and transferred to PVDF membranes (Millipore, Billerica, MA) blocked with 5% nonfat dried milk in TBST (25 mM Tris [pH 7.6], 137 mM NaCl, and 0.2% Tween 20). </plain></SENT>
<SENT sid="60" pm="."><plain>Membranes were incubated with primary antibodies to PKC-α (sc-8393, H-7), PKC-η (sc-215, C-15), and actin (sc-58673, 2Q1055) (Santa Cruz Biotechnology, Santa Cruz, CA) at 4°C overnight, washed with TBST, and incubated with HRP-conjugated secondary antibody. </plain></SENT>
<SENT sid="61" pm="."><plain>Immunoreactive proteins were visualized with luminol reagent (Santa Cruz Biotechnology). </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="62" pm="."><plain>Cytotoxicity assays </plain></SENT>
</text></title><p><text><SENT sid="63" pm="."><plain>The CytoTox-ONE™ Assay (Promega, Madison, WI) was used to measure the release of lactate dehydrogenase (LDH) from cells with a damaged membrane. </plain></SENT>
<SENT sid="64" pm="."><plain>Normalized LDH activity was calculated by subtracting the fluorescent readings in the supernatants of untreated control cells from the experimental sample readings. </plain></SENT>
<SENT sid="65" pm="."><plain>The percentage of necrotic cells was determined as the fluorescence signal measured in the experimental sample relative to the signal obtained from a control sample treated with 0.1% Triton and processed in parallel. </plain></SENT>
<SENT sid="66" pm="."><plain>The results were analyzed using the Synergy2 Multi-Mode Microplate Reader (BioTec, Winooski, VT) at 560 nm excitation and 590 nm emission. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="67" pm="."><plain>ELISA to determine levels of phosphorylated marcks protein </plain></SENT>
</text></title><p><text><SENT sid="68" pm="."><plain>A549 cells (2 × 105) were washed twice in ice-cold PBS and resuspended in 250 μl ice-cold Cell Lysis Buffer (Cell Signaling Technology, Danvers, MA) supplemented with 1 mM PMSF and 1X Halt Protease Inhibitor cocktail (ThermoScientific). </plain></SENT>
<SENT sid="69" pm="."><plain>Whole cell lysates were subjected to centrifugation at 12,000 g for 10 min at 4°C, and the resulting supernatants were analyzed using the PathScan Phospho-MARCKS (Ser152/156) Sandwich ELISA Kit (Cell Signaling Technology) following the manufacturer's instructions. </plain></SENT>
<SENT sid="70" pm="."><plain>Whole cell lysates (in triplicate) were incubated with pMARCKS antibody-coated microwells overnight at 4°C. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="71" pm="."><plain>B. thailandensis intracellular survival </plain></SENT>
</text></title><p><text><SENT sid="72" pm="."><plain>Overnight cultures of A549 cells were infected with B. thailandensis CDC2721121 at the indicated MOI for 2 h at 37°C. </plain></SENT>
<SENT sid="73" pm="."><plain>Cells were washed with PBS and resuspended in DMEM containing 250 μg/ml kanamycin to suppress the growth of extracellular bacteria. </plain></SENT>
<SENT sid="74" pm="."><plain>After 3 h of antibiotic exposure, cells were washed 3 × with PBS and further cultured in antibiotic-free DMEM. </plain></SENT>
<SENT sid="75" pm="."><plain>Prior to analysis, cells were washed with warm PBS and lysed in 0.1% Triton X-100 in PBS for 5 min. </plain></SENT>
<SENT sid="76" pm="."><plain>The lysis mixture was diluted, plated on LB agar plates, incubated overnight at 37°C for growth, and then quantified by colony counts. </plain></SENT>
<SENT sid="77" pm="."><plain>The replication index was calculated as the fold increase of intracellular bacteria between two time points. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="78" pm="."><plain>Analysis of multinucleated giant cell (MNGC) formation </plain></SENT>
</text></title><p><text><SENT sid="79" pm="."><plain>A549 cells infected with Bt CDC2721121 in 6-well plates were washed with PBS and treated with acid ethanol [5% acetic acid (v/v), 5% dH2O and 90% ethanol (v/v)] for 30 min at room temperature. </plain></SENT>
<SENT sid="80" pm="."><plain>Cells were washed twice with PBS and stained with Giemsa solution (0.1% w/v) for 30 s at room temperature. </plain></SENT>
<SENT sid="81" pm="."><plain>After washing with dH2O, cells were air-dried and analyzed using a light microscope. </plain></SENT>
<SENT sid="82" pm="."><plain>At least 10 fields per view at 10 × magnification were analyzed to obtain the percentage of MNGCs, where a cell was considered a MNGC if cell fusions with 3 or more nuclei were present. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="83" pm="."><plain>Gene expression </plain></SENT>
</text></title><p><text><SENT sid="84" pm="."><plain>Total RNA from Burkholderia was isolated using the RNeasy Miniprep Kit (Qiagen, Germantown, MD) and subjected to the TURBO DNA-free Kit (Life Technologies, Grand Island, NY) for DNase treatment and removal. </plain></SENT>
<SENT sid="85" pm="."><plain>100 ng purified RNA was used for quantitative real-time PCR with the TaqMan RNA-to-CT 1-Step kit following the manufacturer's instructions (Life Technologies). </plain></SENT>
<SENT sid="86" pm="."><plain>Transcripts were normalized to 18S ribosomal RNA levels, using the VIC-MGB primer limited set, and calculated relative to the control sample using the 2T-ΔΔC method. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="87" pm="."><plain>Imaging flow cytometry to quantify autophagosomes and cytoplasmic B. thailandensis </plain></SENT>
</text></title><p><text><SENT sid="88" pm="."><plain>A549 cells expressing RFP-LC3B were grown on Corning-Costar 96-well plates with coverslip bottoms and treated with 10 μM rapamycin or infected with Bt CDC2721121 at MOI 10. </plain></SENT>
<SENT sid="89" pm="."><plain>Cells were fixed with 4% paraformaldehyde 5 h post-treatment, washed with PBS, and stored in ProLong Gold mount with DAPI nuclear stain (LifeTechnologies). </plain></SENT>
<SENT sid="90" pm="."><plain>Samples were acquired at optimized laser strength (100 mW for 488) with an area classifier (number of pixels in μm2) set at 50 using a Zeiss inverted fluorescence microscope. </plain></SENT>
<SENT sid="91" pm="."><plain>Images were acquired for each cell at 60 × magnification and enhanced depth of perception. ~2,000 cells were analyzed for each experimental or isotype control sample, and 500 cells were acquired for each single positive compensation control sample. </plain></SENT>
<SENT sid="92" pm="."><plain>The integrated software INSPIRE (version 6.0.154, Amnis) was used for data collection. </plain></SENT>
<SENT sid="93" pm="."><plain>Gating was determined for each experimental sample and cut-offs were defined using an untreated A549-RFP-LC3 control sample. </plain></SENT>
<SENT sid="94" pm="."><plain>All single and focused cells used in our analysis had zero saturated pixels. </plain></SENT>
<SENT sid="95" pm="."><plain>LC3 positive spots were identified by creating a spot mask for peak intensities that were greater than background. </plain></SENT>
<SENT sid="96" pm="."><plain>The peak to background ratio was determined for each experiment based on untreated controls. </plain></SENT>
<SENT sid="97" pm="."><plain>This spot mask was then converted into a spot count feature. </plain></SENT>
<SENT sid="98" pm="."><plain>The bacteria and LC3 spot counts were plotted against a normalized frequency of cells to generate histograms. </plain></SENT>
<SENT sid="99" pm="."><plain>To determine the bacterial counts in the cytoplasm that were not associated with LC3-positive spots, we used the following algorithm: Spot {Intensity (MO2, Ch02, 114-4095), Ch02 Bright, 16.25, 1}, and Not Spot {Intensity (M04,ch04, 240-4095), Ch04, Bright, 4, 1}. </plain></SENT>
<SENT sid="100" pm="."><plain>Analysis was performed on the compensated image files using algorithms in IDEAS (version 5.0, Amnis) image analysis software. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="101" pm="."><plain>Statistical analysis </plain></SENT>
</text></title><p><text><SENT sid="102" pm="."><plain>One-way ANOVA and Z-test were used to evaluate the significance of responses in the HTS experiments. </plain></SENT>
<SENT sid="103" pm="."><plain>For samples n ≥ 3, the statistical significance of the difference between experimental and control data sets was determined via Student's t-test and the normal distributions for multiple-comparisons of experimental samples were confirmed using the Tukey-Kramer test where we specified that the entire set of comparisons should have a family error rate of 0.05. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="RESULTS"><sec sec-type="results" id="s3"><title><text><SENT sid="104" pm="."><plain>Results </plain></SENT>
</text></title><sec><title><text><SENT sid="105" pm="."><plain>RNAi-based gene silencing screen of host kinases in host-B. thailandensis interactions </plain></SENT>
</text></title><p><text><SENT sid="106" pm="."><plain>We performed a functional genomic screen using a siRNA library against 718 annotated human kinases or kinase-interacting proteins to identify host proteins required for B. thailandensis survival in human monocytic THP-1 cells (Supplementary Materials and Methods and Supplementary Table 1). </plain></SENT>
<SENT sid="107" pm="."><plain>We identified 35 initial hits (Table 1), in which siRNA-mediated gene silencing resulted in ≥50% reduction in host cell-associated bacteria. </plain></SENT>
<SENT sid="108" pm="."><plain>Genes encoding kinases that play a role in host cell survival pathways were highly represented in our screen. </plain></SENT>
<SENT sid="109" pm="."><plain>Screen hits also included kinases that regulate cell adhesion and actin dynamics, cell processes that are essential for phagocytosis of intracellular bacteria (Kuijl et al., 2007). </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="T1" position="float"><label>Table 1</label><caption><p><text><SENT sid="110" pm="."><plain>Host genes required for intracellular B. thailandensis proliferation. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="111" pm="."><plain>Gene name </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="112" pm="."><plain>Accession no. </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="113" pm="."><plain>Biochemical activity </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="114" pm="."><plain>Biological function </plain></SENT>
</text></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="115" pm="."><plain>ABL1 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="116" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_005157">NM_005157</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="117" pm="."><plain>Protein tyrosine kinase </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="118" pm="."><plain>Cell division differentiation, adhesion, and stress </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="119" pm="."><plain>AKT1/PKB </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="120" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_005163">NM_005163</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="121" pm="."><plain>Serine/threonine-protein kinase </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="122" pm="."><plain>Cell survival, growth, proliferation, motility </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="123" pm="."><plain>AKT2/PKBB </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="124" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_005163">NM_005163</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="125" pm="."><plain>Serine/threonine-protein kinase </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="126" pm="."><plain>Cell survival, insulin signaling, motility </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="127" pm="."><plain>AURKA </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="128" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_198437">NM_198437</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="129" pm="."><plain>Cell cycle-regulated serine/threonine kinase </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="130" pm="."><plain>Organizing microtubules during cell division </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="131" pm="."><plain>AURKC </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="132" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_198437">NM_198437</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="133" pm="."><plain>Serine/threonine/tyrosine kinase </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="134" pm="."><plain>Mitosis and meiosis </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="135" pm="."><plain>CALM1 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="136" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_006888">NM_006888</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="137" pm="."><plain>Calcium binding phosphorylase kinase </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="138" pm="."><plain>Centrosome cycle, cytokinesis, cell signaling </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="139" pm="."><plain>CAMK1G </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="140" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_020439">NM_020439</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="141" pm="."><plain>Ca++/calmodulin-dependent kinase </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="142" pm="."><plain>Ca++-triggered signaling cascade </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="143" pm="."><plain>CAMK2A </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="144" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_015981">NM_015981</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="145" pm="."><plain>Serine/threonine kinase </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="146" pm="."><plain>Gene transcription, cell survival, apoptosis, cytoskeleton </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="147" pm="."><plain>CAMK2B </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="148" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_172084">NM_172084</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="149" pm="."><plain>Serine/threonine kinase </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="150" pm="."><plain>Same as CAMK2A </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="151" pm="."><plain>CAMKK2 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="152" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_172215">NM_172215</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="153" pm="."><plain>Ca++/calmodulin-dependent serine/threonine kinase </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="154" pm="."><plain>Gene transcription, cell survival, cytoskeleton reorganization </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="155" pm="."><plain>EPHA3 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="156" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_182644">NM_182644</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="157" pm="."><plain>Receptor protein-tyrosine kinase </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="158" pm="."><plain>Cell signaling, development, migration </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="159" pm="."><plain>EPHB2 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="160" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_004443">NM_004443</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="161" pm="."><plain>Receptor protein-tyrosine kinase </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="162" pm="."><plain>Cell signaling, development, migration, and adhesion </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="163" pm="."><plain>ERBB3/ cErbB3 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="164" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_001005915">NM_001005915</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="165" pm="."><plain>Receptor tyrosine kinase </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="166" pm="."><plain>Gene expression, cytoskeletal rearrangement, cell survival </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="167" pm="."><plain>HK1 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="168" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_000188">NM_000188</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="169" pm="."><plain>Produce glucose-6-phosphate </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="170" pm="."><plain>Glycolysis, energy generation </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="171" pm="."><plain>HK2 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="172" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_000189">NM_000189</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="173" pm="."><plain>Produce glucose-6-phosphate </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="174" pm="."><plain>Glycolysis, energy generation </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="175" pm="."><plain>HK3 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="176" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_002115">NM_002115</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="177" pm="."><plain>Produce glucose-6-phosphate </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="178" pm="."><plain>Glycolysis, energy generation </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="179" pm="."><plain>INSRR </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="180" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_014215">NM_014215</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="181" pm="."><plain>Transmembrane receptor protein tyrosine kinase </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="182" pm="."><plain>Cell signaling, apoptosis, pH sensor </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="183" pm="."><plain>ITPKA/IP3KA </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="184" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_002220">NM_002220</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="185" pm="."><plain>Phosphorylation of inositol 1,4,5-trisphosphate to Ins (1,3,4,5) P4 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="186" pm="."><plain>Cell signaling, motility </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="187" pm="."><plain>KDR </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="188" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_002253">NM_002253</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="189" pm="."><plain>Receptor protein-tyrosine kinase </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="190" pm="."><plain>Proliferation, survival, migration </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="191" pm="."><plain>MAST3 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="192" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_015016">NM_015016</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="193" pm="."><plain>Serine/threonine kinase </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="194" pm="."><plain>Mitosis </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="195" pm="."><plain>PAK3 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="196" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_002578">NM_002578</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="197" pm="."><plain>Serine/threonine p21-activating kinase </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="198" pm="."><plain>Cell cycle, migration </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="199" pm="."><plain>PIK3R1 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="200" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_181523">NM_181523</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="201" pm="."><plain>Phosphorylation of the inositol ring of PI at the 3′ position </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="202" pm="."><plain>Cell signaling, vesicular trafficking, migration, insulin metabolism </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="203" pm="."><plain>PIK3R5/P101-PI3K </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="204" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_14308">NM_14308</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="205" pm="."><plain>Phosphorylation of the 3'OH of the inositol ring of phosphoinositide (PI) </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="206" pm="."><plain>Cell growth, proliferation, differentiation, motility, and intracellular trafficking </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="207" pm="."><plain>PIP5KIA </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="208" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_003557">NM_003557</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="209" pm="."><plain>Phosphorylation of 4-phosphate of PI </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="210" pm="."><plain>Endocytosis and cell migration </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="211" pm="."><plain>PIP5K2B </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="212" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_003559">NM_003559</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="213" pm="."><plain>Phosphorylation of 5′-phosphate of PI at the 4′OH </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="214" pm="."><plain>Cell signaling, proliferation, motility </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="215" pm="."><plain>PKN3 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="216" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_013355">NM_013355</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="217" pm="."><plain>Serine/threonine-protein kinase </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="218" pm="."><plain>Cell growth, migration, adherence </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="219" pm="."><plain>PRKCH </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="220" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_006255">NM_006255</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="221" pm="."><plain>Serine/threonine-protein kinase </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="222" pm="."><plain>Cell signaling, proliferation, survival, motility </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="223" pm="."><plain>PTK7 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="224" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_152881">NM_152881</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="225" pm="."><plain>Transduction of extracellular signals across the cell membrane </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="226" pm="."><plain>Wnt cell signaling, polarity, adhesion </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="227" pm="."><plain>PRKACB/PKA C-β </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="228" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_002731">NM_002731</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="229" pm="."><plain>cAMP-dependent catalytic subunit of serine/threonine-protein kinase </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="230" pm="."><plain>Regulation of lipid and glucose metabolism, cell signaling </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="231" pm="."><plain>PCK1 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="232" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_002591">NM_002591</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="233" pm="."><plain>Catalyzes the formation of phosphoenolpyruvate from oxaloacetate </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="234" pm="."><plain>Regulation of gluconeogenesis </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="235" pm="."><plain>STK11/LKB1 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="236" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_000455">NM_000455</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="237" pm="."><plain>Serine/threonine kinase, phosphorylates AMPK </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="238" pm="."><plain>Cell polarity and survival, metabolic reprogramming </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="239" pm="."><plain>STK35/CLIK1 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="240" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_080836">NM_080836</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="241" pm="."><plain>Serine/threonine kinase </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="242" pm="."><plain>Cell cycle, migration </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="243" pm="."><plain>STK38L/NDR1 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="244" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_015000">NM_015000</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="245" pm="."><plain>Mg++ binding serine/threonine kinase </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="246" pm="."><plain>Cytoskeletal reorganization, cell invasion </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="247" pm="."><plain>STK4 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="248" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_006282">NM_006282</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="249" pm="."><plain>Serine/threonine kinase </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="250" pm="."><plain>apoptosis </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="251" pm="."><plain>TYRO3 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="252" pm="."><plain><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_006293">NM_006293</ext-link> </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="253" pm="."><plain>Receptor protein-tyrosine kinase </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="254" pm="."><plain>Cell survival, proliferation and regulation </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag><p><text><SENT sid="255" pm="."><plain>For subsequent validation studies, we used the clinical isolate B. thailandensis CDC2721121. </plain></SENT>
<SENT sid="256" pm="."><plain>We applied differential fluorescent labeling of extracellular and intracellular Bt CDC2721121 to assess the efficiency of pathogen internalization and survival within THP-1 cells using imaging flow cytometry (Figure 1A). </plain></SENT>
<SENT sid="257" pm="."><plain>We observed that siRNA-mediated silencing of six genes regulating actin dynamics (PTK7, EPHB2, and PRKCH), calcium signaling (CALM1), cell adhesion (STK35), and cell proliferation (STK38L) resulted in a significant (z&gt;-2) reduction of B. thailandensis intracellular load in THP-1 cells, compared to cells treated with control siRNA (Figure 1B, Supplementary Table 2). </plain></SENT>
<SENT sid="258" pm="."><plain>The RNAi silencing of target gene activity in monocytic THP-1 cells was efficient (&gt;75%), transcript-specific (Supplementary Figure 1), and did not affect host cell viability when compared to the control cells treated with non-targeting siRNA (Supplementary Figure 2). </plain></SENT>
</text></p><SecTag type="FIG"><fig id="F1" position="float"><label>Figure 1</label><caption><p><text><SENT sid="259" pm="."><plain>Differential fluorescent labeling of intracellular B. thailandensis upon siRNA knockdown of selected host kinase genes. (A) THP-1 cells pretreated with 50 nM siRNA for 72 h were infected with FITC-labeled Bt CDC2721121 for 2 h at MOI 10. </plain></SENT>
<SENT sid="260" pm="."><plain>Kanamycin (250 μg/ml) was then added for 3 h to suppress extracellular bacterial growth, after which the infected cells were cultured in antibiotic-free media for 20 h. </plain></SENT>
<SENT sid="261" pm="."><plain>Bacterial cells remaining extracellular were double-labeled with FITC and B. thailandensis rabbit antiserum/PE-conjugated anti-rabbit IgG, whereas intracellular bacteria were single-labeled with only FITC. </plain></SENT>
<SENT sid="262" pm="."><plain>Imaging flow cytometry analysis of infected THP-1 cells was performed using the Amnis ImageStreamX, and the frequencies of singly and double labeled bacteria were determined using the IDEAS 5.0 software. </plain></SENT>
<SENT sid="263" pm="."><plain>FITC, fluorescein isothiocyanate (ex495 nm/em519 nm); PE, Phycoerythrin (ex 488 nm/em575 nm). (B) The ratio of extracellular vs. intracellular bacteria in THP-1 cells siRNA-depleted of target kinases was used to evaluate kinase function in intracellular B. thailandensis proliferation. </plain></SENT>
<SENT sid="264" pm="."><plain>The average and standard deviation were determined from three independent experiments (Supplementary Table 2). </plain></SENT>
<SENT sid="265" pm="."><plain>The “*” denotes statistical significance (p &lt; 0.05) for the ratio of extracellular to intracellular pathogen in cells siRNA-depleted of target gene compared to cells treated with control siRNA. </plain></SENT>
</text></p></caption><graphic xlink:href="fcimb-07-00231-g0001"/></fig></SecTag></sec><sec><title><text><SENT sid="266" pm="."><plain>Differential role of conventional and novel PKC isoforms in B. thailandensis survival in human monocytes </plain></SENT>
</text></title><p><text><SENT sid="267" pm="."><plain>We focused our study on PRKCH, which encodes for PKC-η, a novel protein kinase C isoform that requires diacylglycerol (DAG), but not Ca2+, for activation. </plain></SENT>
<SENT sid="268" pm="."><plain>Interestingly, we did not recover any classical Ca2+-dependent PKC isoforms (α, β, and γ), which are known to be key regulators of opsonized antigen phagocytosis (Underhill and Ozinsky, 2002). </plain></SENT>
<SENT sid="269" pm="."><plain>To further examine the differential functions of conventional and novel PKC isoforms in B. thailandensis CDC2721121 survival within host cells, we compared the intracellular bacterial load in THP-1 cells siRNA-depleted of PKC-η or PKC-α. </plain></SENT>
<SENT sid="270" pm="."><plain>Upon downregulation of PKC-η, the average number of intracellular B. thailandensis per THP-1 cell dropped by &gt;4-fold compared to control (CTL) cells (Figure 2A). </plain></SENT>
<SENT sid="271" pm="."><plain>In comparison, downregulation of PKC-α resulted in decreased intracellular bacterial count per host cell by &lt; 2-fold. </plain></SENT>
<SENT sid="272" pm="."><plain>By Western blot, we observed that siRNA directed toward the PRKCH transcripts was specific, causing the depletion of PKC-η, but not PKC-α protein (Figure 2B). </plain></SENT>
<SENT sid="273" pm="."><plain>To further test PKC isoform specificity, we examined the induction of host cell death by B. thailandensis CDC2721121 infection in lung epithelial A549 cells. </plain></SENT>
<SENT sid="274" pm="."><plain>This cell model has been previously used to examine Burkholderia replication in non-phagocytic cells via formation of polymorphonuclear cells (Wongprompitak et al., 2009; Kunyanee et al., 2016). </plain></SENT>
<SENT sid="275" pm="."><plain>We transiently expressed dominant-negative mutants of PKC-η (PKC-η-DN) and PKC-α (PKC-α-DN), and a constitutively-active PKC-η (PKC-η-CAT), which lacks the N-terminal regulatory domain, in A549 cells (Soh and Weinstein, 2003). </plain></SENT>
<SENT sid="276" pm="."><plain>Despite the great data variability originating from transient transfection experiments we observed that cells expressing PKC-η-DN demonstrated reduced host cell death by ~3-fold in response to Bt CDC2721121 infection, whereas expression of PKC-α-DN had no significant effect, compared to A549 cells carrying empty vector (CTL) or PKC-η-CAT (Figure 2C). </plain></SENT>
<SENT sid="277" pm="."><plain>These results indicate that the novel PKC-η isoform plays a more significant role in B. thailandensis intracellular survival and induction of host cell death, compared to the conventional PKC-α isoform. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="F2" position="float"><label>Figure 2</label><caption><p><text><SENT sid="278" pm="."><plain>PKC-η plays bigger role than PKC-α in unopsonized B. thailandensis intracellular survival and induction of host cell death. (A) Quantitative analysis of internalized Bt CDC2721121 was determined by plotting bacteria spot counts, 1–2 μm fluorescent puncti corresponding to bacteria size and fluorescent marker, against a normalized frequency, percentage of analyzed cells selected from the total number of single and focused cells. </plain></SENT>
<SENT sid="279" pm="."><plain>Bacterial counts in the cytoplasm that were singly labeled with FITC and not associated with the PE-labeled extracellular bacterial spots were calculated as described in the Materials and Methods. </plain></SENT>
<SENT sid="280" pm="."><plain>R, the gate excluding the cells exhibiting background fluorescence from the analysis, shows the mean value of fluorescence (MF) spots associated with intracellular bacteria per single host cell. </plain></SENT>
<SENT sid="281" pm="."><plain>R and NF (Normalized frequency) were determined by selective analysis of at least 5000 single and focused cells per sample using the IDEAS 5.0 software. </plain></SENT>
<SENT sid="282" pm="."><plain>A representative result of one out of 3 independent experiments is shown. (B) THP-1 cells were transfected with 50 nM siRNA against PRKCH or non-targeting control (CTL) siRNA and collected 72 h post treatment. </plain></SENT>
<SENT sid="283" pm="."><plain>Whole cell lysates were analyzed by Western blot using antibodies against PKC-η, PKC-α, and actin. (C) A549 cells transiently expressing PKC-η-DN, PKC-α-DN, and PKC-η-CAT, were infected with Bt CDC2721121 at MOI 50 for 1 h, treated with kanamycin (250 μg/ml) for 3 additional hours to suppress extracellular bacterial growth, after which the infected cells were cultured in antibiotic-free media. </plain></SENT>
<SENT sid="284" pm="."><plain>At 40 h post-infection, the percentage of dead A549 cells was calculated as a ratio of LDH activity in the conditioned media relative to total enzyme activity in the infected cells lysed with 0.1% Triton. </plain></SENT>
<SENT sid="285" pm="."><plain>The average and standard deviation from three independent experiments are shown. </plain></SENT>
<SENT sid="286" pm="."><plain>The “*” denotes statistical significance (p &lt; 0.05) for % cell death in transfected samples compared to infected cells transfected with an empty vector (CTL) for each experimental condition. </plain></SENT>
</text></p></caption><graphic xlink:href="fcimb-07-00231-g0002"/></fig></SecTag></sec><sec><title><text><SENT sid="287" pm="."><plain>Intracellular survival of B. thailandensis is dependent on MARCKS phosphorylation by PKC-η </plain></SENT>
</text></title><p><text><SENT sid="288" pm="."><plain>The respiratory epithelium and nasal-associated lymphoid tissue serve as primary entry points for inhalational melioidosis (Owen et al., 2009). Burkholderia invades host cells via phagocytosis, escapes the membrane-bound phagosome, and disseminates in the host cytoplasm to maintain an intracellular niche (Jones et al., 1996). </plain></SENT>
<SENT sid="289" pm="."><plain>We investigated a potential role for PKC-η function in the activation of a downstream effector protein, MARCKS, upon Burkholderia thailandensis phagocytosis. </plain></SENT>
<SENT sid="290" pm="."><plain>MARCKS, an ~87 kD protein, functions as an actin cross-linking protein and a signal transducer in PKC-dependent pathways. </plain></SENT>
<SENT sid="291" pm="."><plain>MARCKS is activated by PKC-catalyzed phosphorylation of a conserved 25 aa basic effector domain (ED). </plain></SENT>
<SENT sid="292" pm="."><plain>Although MARCKS phosphorylation by the conventional PKC-α has been previously found to facilitate zymosan adherence to macrophage cells and promote phagocytosis (Allen and Aderem, 1995b), the role of novel PKC isoforms on MARCKS function in response to bacterial infection has not yet been investigated. </plain></SENT>
</text></p><p><text><SENT sid="293" pm="."><plain>We detected a ~2–3-fold increase in phosphorylated MARCKS (pMARCKS) protein levels when normalized to total MARCKS protein in A549 cells infected with Bt CDC2721121 for 30, 60, or 180 min, compared to pMARCKS in uninfected cells, using an ELISA specific for MARCKS phosphorylation at Ser175/160 of the ED (Figure 3A). </plain></SENT>
<SENT sid="294" pm="."><plain>Interestingly, we also observed a time-dependent response to infection with a different Gram-negative pathogen, Yersinia entercolitica, in which pMARCKS levels increased from ~1.5-fold at 30 min post-infection to ~5-fold at 60 min, but decreased to basal levels at 180 min. </plain></SENT>
<SENT sid="295" pm="."><plain>This finding is consistent with the known virulence mechanisms of pathogenic Yersinia spp. employing a T3SS to inject Yop effector proteins into the host cells within180 min of infection to inhibit actin polymerization and the host phagocytic response (Zauberman et al., 2006). </plain></SENT>
<SENT sid="296" pm="."><plain>In comparison, the potent PKC stimulator PMA induced a ~15-fold increase in pMARCKS levels after 30 min and an ~8-fold increase after 60 and 180 min. </plain></SENT>
<SENT sid="297" pm="."><plain>We also observed that siRNA-mediated knockdown of either MARCKS or PKC-η expression in A549 cells reduced pMARCKS levels by &gt;3-fold in response to 30 or 60 min of infection with Bt CDC2721121, compared to host cells treated with non-targeting siRNA (siR-CTL) (Figure 3B). </plain></SENT>
<SENT sid="298" pm="."><plain>These data indicate that PKC-η participates in MARCKS ED phosphorylation upon infection of lung epithelial cells with Gram-negative bacteria. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="F3" position="float"><label>Figure 3</label><caption><p><text><SENT sid="299" pm="."><plain>PKC-η is involved in host MARCKS phosphorylation upon bacterial infection (A) A549 cells were infected with Bt CDC2721121 at MOI 50 or Y. enterocolitica WA at MOI 20. </plain></SENT>
<SENT sid="300" pm="."><plain>After the indicated times, cells were lysed and levels of phosphorylated Ser152/156 in the MARCKS effector domain (pMARCKS) were quantified using the PathScan ELISA kit and compared to uninfected A549 cells. </plain></SENT>
<SENT sid="301" pm="."><plain>Cells were also treated with 100 nM PMA as a positive control. </plain></SENT>
<SENT sid="302" pm="."><plain>In all samples, pMARCKS levels were normalized to the total MARCKS protein levels. </plain></SENT>
<SENT sid="303" pm="."><plain>The average and standard deviation from three independent experiments are shown. (B) A549 cells were treated with 25 nM siRNA against MARCKS, PKC-η, or non-targeting control (CTL) for 72 h prior to infection with Bt CDC2721121. </plain></SENT>
<SENT sid="304" pm="."><plain>At the indicated time, cells were lysed and the levels of pMARCKS were quantified as fold change relative to uninfected A549 cells. </plain></SENT>
<SENT sid="305" pm="."><plain>The average and standard deviation from three independent experiments are shown. </plain></SENT>
<SENT sid="306" pm="."><plain>The “*” denotes statistical significance (p &lt; 0.05) for fold pMARCKS change in samples treated with siRNA to MARCKS or PKC-η, compared to non-targeting siRNA samples (siR-CTL). </plain></SENT>
</text></p></caption><graphic xlink:href="fcimb-07-00231-g0003"/></fig></SecTag><p><text><SENT sid="307" pm="."><plain>To further link PKC-η and MARCKS function to bacterial survival within host cells, we demonstrated that PKC-η or MARCKS depletion via siRNA resulted in a ~10-fold and ~2.5-fold reduction, respectively, in the number of viable intracellular B. thailandensis in A549 cells following infection for 24 h, compared to cells treated with non-targeting siRNA (siR-CTL) (Figure 4A, light gray bars). </plain></SENT>
<SENT sid="308" pm="."><plain>This decrease in intracellular Burkholderia counts correlated with increased A549 viability of PKC-η– or MARCKS-depleted cells, as measured by a ~2-fold reduction in LDH release (Figure 4A, dark gray bars). </plain></SENT>
<SENT sid="309" pm="."><plain>We also examined multi-nucleated giant cell (MNGC) formation as a result of Burkholderia-induced host cell fusion (Suparak et al., 2005; Galyov et al., 2010). </plain></SENT>
<SENT sid="310" pm="."><plain>Reduction of gene expression via MARCKS transcript-specific siRNA resulted in ~2-fold less MNGC counts as compared to A549 cells treated with non-targeting siRNA (siR-CTL) (Figure 4B). </plain></SENT>
<SENT sid="311" pm="."><plain>A statistically marginal difference between controls and experimental samples was observed in most assays where the MARCKS transcript levels were reduced via RNAi. </plain></SENT>
<SENT sid="312" pm="."><plain>There could be two logical explanations for this phenomenon, (i) native MARCKS transcript levels increase upon bacterial infection (see Figure 6B) counteracting the effect of the siRNA on MARCKS transcripts and (ii) MARCKS most probably competes with other PKC-η substrates, including MacMARCKS and proteins referred to as STICKs (substrates that interact with C-kinase) (Chapline et al., 1998). </plain></SENT>
<SENT sid="313" pm="."><plain>Altogether, our data suggest that MARCKS activation is dependent on PKC-η function, and both proteins are involved in Burkholderia-induced host cell pathology following infection. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="F4" position="float"><label>Figure 4</label><caption><p><text><SENT sid="314" pm="."><plain>Intracellular survival and spread of pathogenic Burkholderia is dependent on PKC-η and MARCKS function. (A) A549 cells were treated with 20 nM siRNA targeting MARCKS or PKC-η for 72 h prior to infection with Bt CDC2721121 at MOI 50. </plain></SENT>
<SENT sid="315" pm="."><plain>After 2 h of infection, cells were treated with 250 μg/ml kanamycin for 3 h, and incubated overnight in antibiotic-free media. </plain></SENT>
<SENT sid="316" pm="."><plain>Cells were collected 24 h post-infection and lysed with 0.1% Triton to release the intracellular bacteria. </plain></SENT>
<SENT sid="317" pm="."><plain>Colony forming units (CFU) were calculated from limiting dilutions of the cell lysates incubated on nutrient agar for 24 h at 37°C. </plain></SENT>
<SENT sid="318" pm="."><plain>LDH activity was measured in conditioned media and is presented as fold increase in the 24 vs. 2 h post infection. </plain></SENT>
<SENT sid="319" pm="."><plain>The average and standard deviation from three independent experiments are shown. </plain></SENT>
<SENT sid="320" pm="."><plain>The “*” denotes statistical significance (p &lt; 0.05) for CFU counts and relative LDH activity in samples treated with siRNA to MARCKS or PKC-η, compared to control samples (siR-CTL). (B) A549 cells were treated with 20 nM siRNA against MARCKS or with non-targeting (siR-CTL) siRNA 72 h prior to infection with Bt CDC2721121 at MOI 50. </plain></SENT>
<SENT sid="321" pm="."><plain>Cells were fixed 18 h post-infection, stained with Giemsa, and the percentage of MNGC formation was calculated relative to normal cells per field of view. </plain></SENT>
<SENT sid="322" pm="."><plain>The average and standard deviations were derived from at least 10 fields of view covering an entire 20 mm culture dish. </plain></SENT>
<SENT sid="323" pm="."><plain>The “*” denotes statistical significance (p &lt; 0.05) for % MNGC in samples treated with siRNA to MARCKS compared to samples treated with control siRNA (siR-CTL). </plain></SENT>
<SENT sid="324" pm="."><plain>The scale bar is 60 μM in length. </plain></SENT>
</text></p></caption><graphic xlink:href="fcimb-07-00231-g0004"/></fig></SecTag></sec><sec><title><text><SENT sid="325" pm="."><plain>PKC-η regulates MARCKS phosphorylation upon engagement of mannose receptors by unopsonized B. thailandensis </plain></SENT>
</text></title><p><text><SENT sid="326" pm="."><plain>Pathogen uptake via phagocytosis is initiated by a recognition event between a specific host receptor and microbial cell surface molecules, such as lipopolysaccharide or opsonins (e.g., antibodies) that coat the bacteria. </plain></SENT>
<SENT sid="327" pm="."><plain>Mannose receptors (MR) play a significant role in the uptake of unopsonized bacteria (Geier and Celli, 2011), but have not yet been found to play a role in microbicidal phagocytic pathways (Astarie-Dequecker et al., 1999). </plain></SENT>
<SENT sid="328" pm="."><plain>Interestingly, MARCKS was previously reported to function in the phagocytosis of zymosan particles that engage MRs (Carballo et al., 1999). </plain></SENT>
<SENT sid="329" pm="."><plain>To investigate whether B. thailandensis CDC2721121 can activate MARCKS phosphorylation via MR engagement, we quantified pMARCKS levels in A549 cells treated with purified mannan to saturate the MRs. </plain></SENT>
<SENT sid="330" pm="."><plain>A549 cells pre-incubated with mannan exhibited a ~1.5–2-fold decrease in pMARCKS levels following infection with Bt CDC2721121, compared to infected cells not treated with mannan (CTL), suggesting that MARCKS phosphorylation is at least partly dependent on MR engagement by the pathogen (Figure 5A, light gray). </plain></SENT>
<SENT sid="331" pm="."><plain>Alternatively, coating Bt CDC2721121 with an opsonin, rabbit anti-B.th serum, to block potential interactions between MRs and the pathogen, resulted in ~2-fold reduction of pMARCKS levels in A549 cells. </plain></SENT>
<SENT sid="332" pm="."><plain>Notably, both conditions decreased the efficiency of Bt CDC2721121 infection, reducing the replication index of intracellular Bt CDC2721121 in A549 cells by ~2-fold (Figure 5A, dark gray). </plain></SENT>
<SENT sid="333" pm="."><plain>These data suggest that MARCKS phosphorylation is triggered upon interaction of Bt CDC2721121-associated cell surface molecular patterns (eg. mannan polysacharides) with lung epithelial A549 cell receptors, including MR. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="F5" position="float"><label>Figure 5</label><caption><p><text><SENT sid="334" pm="."><plain>Phagocytosis receptor usage determines the efficiency of intracellular Burkholderia proliferation. </plain></SENT>
<SENT sid="335" pm="."><plain>(A) A549 cells were (1) incubated with 3 mg/ml soluble mannan for 30 min and then infected with unopsonized Bt CDC2721121 at MOI 50, (2) not treated with mannan and infected with Bt CDC2721121 coated with anti-B.thailandensis rabbit serum (opson Bt), or (3) not treated with mannan and uninfected (CTL). </plain></SENT>
<SENT sid="336" pm="."><plain>pMARCKS levels in bacteria-infected cells were quantified and compared to uninfected cells. </plain></SENT>
<SENT sid="337" pm="."><plain>In parallel, A549 cells were collected after 2 h of infection for determination of intracellular bacterial counts. </plain></SENT>
<SENT sid="338" pm="."><plain>These cells were treated with 250 μg/ml kanamycin for 3 h to inhibit extracellular bacterial growth and incubated overnight in antibiotic-free media. </plain></SENT>
<SENT sid="339" pm="."><plain>At 24 h post-infection, a second set of samples were collected, and colony forming units (CFU) were calculated from limiting dilutions of the cell lysates incubated on nutrient agar for 24 h at 37°C. </plain></SENT>
<SENT sid="340" pm="."><plain>The replication index of intracellular Bt CDC2721121 was calculated as the CFU fold change at 24 vs. 2 h post-infection. </plain></SENT>
<SENT sid="341" pm="."><plain>The average and standard deviation from three independent experiments are shown. </plain></SENT>
<SENT sid="342" pm="."><plain>The “*” denotes statistical significance (p &lt; 0.05) for fold change in pMARCKS and replication index in host cells treated with mannan or pathogen coated with serum, compared to CTL samples. (B) A549 and THP-1 cells were treated as described in (A), and LDH activity was measured in conditioned media 2 h post infection. </plain></SENT>
<SENT sid="343" pm="."><plain>After treatment with kanamycin (250 μg/ml) for 3 h, host cells were incubated for 24 h in antibiotic-free media and a second LDH measurement was taken. </plain></SENT>
<SENT sid="344" pm="."><plain>Relative LDH activity was determined as fold change between the 24 h and 2 h time points post-infection. </plain></SENT>
<SENT sid="345" pm="."><plain>The average and standard deviation from three independent experiments are shown. </plain></SENT>
<SENT sid="346" pm="."><plain>The “*” denotes statistical significance (p &lt; 0.05) for relative LDH activity in experimental samples compared to untreated (CTL) samples. (C) A549 cells were treated with 25 nM siRNA targeting MRC1 or with non-targeting (CTL) siRNA and were infected with unopsonized Bt CDC2721121 at MOI 50. </plain></SENT>
<SENT sid="347" pm="."><plain>At 1 h and 24 h post-infection, cells were lysed with 0.1% Triton, and colony forming units (CFU) were calculated from limiting dilutions of the cell lysates incubated on nutrient agar for 24 h at 37°C. </plain></SENT>
<SENT sid="348" pm="."><plain>The ratio of CFU corresponding to intracellular bacteria from siR-MRC1 treated cells vs. cells treated with non-targeting siRNA is shown for each time point. </plain></SENT>
<SENT sid="349" pm="."><plain>The average mean and standard deviation from three independent experiments are shown. </plain></SENT>
<SENT sid="350" pm="."><plain>The “*” denotes statistical significance (p &lt; 0.05) in number of CFUs between 1 and 24 h. </plain></SENT>
</text></p></caption><graphic xlink:href="fcimb-07-00231-g0005"/></fig></SecTag><p><text><SENT sid="351" pm="."><plain>Consistent with these observations, both mannan pre-treatment and infection with serum-optimized Bt CDC2721121 had a positive effect on A549 host cell viability, as measured by a decrease in extracellular LDH activity (Figure 5B). </plain></SENT>
<SENT sid="352" pm="."><plain>In contrast, survival of THP-1 cells treated with mannan did not significantly differ from untreated cells (CTL) following infection. </plain></SENT>
<SENT sid="353" pm="."><plain>This difference in host cell survival between A549 (epithelial) and THP-1 (monocytic) cells upon mannan treatment is likely due to the lower expression levels of MR on monocytes prior to their differentiation into macrophages (Rouleux-Bonnin et al., 1995; Wollenberg et al., 2002). </plain></SENT>
<SENT sid="354" pm="."><plain>We also observed that serum-opsonized Bt CDC2721121 induced a rapid decline in THP-1 viability upon infection, suggesting activation of cell death mechanisms, possibly through Fc receptor (FcR) signaling triggered by antibody opsonins (Underhill and Ozinsky, 2002). </plain></SENT>
<SENT sid="355" pm="."><plain>Finally, we siRNA-depleted MRC1 (mannose receptor C type 1, CD206) transcripts from A549 cells and observed ~60% reduction in bacterial uptake after 1 h post-infection, relative to host cells treated with non-targeting siRNA (Figure 5C). </plain></SENT>
<SENT sid="356" pm="."><plain>However, we detected no difference in the intracellular Bt CDC2721121 counts between siR-MRC1-treated and control A549 cells after 24 h of infection. </plain></SENT>
<SENT sid="357" pm="."><plain>These results suggest that mannose receptors facilitate initial B. thailandensis uptake but do not significantly contribute to the activation of cellular defense mechanisms that restrict intracellular bacterial growth over time. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="358" pm="."><plain>PKC-η facilitates B. thailandensis escape into the host cytoplasm </plain></SENT>
</text></title><p><text><SENT sid="359" pm="."><plain>To determine whether the opsonization state of Burkholderia can affect stimulation of macroautophagy, we quantified expression of ATG7, a regulator of autophagosome formation (Geng and Klionsky, 2008), in response to infection with unopsonized and serum-opsonized Bt CDC2721121. </plain></SENT>
<SENT sid="360" pm="."><plain>We observed ~3-fold increase in ATG7 expression at 5 h post-infection of THP-1 cells with unopsonized Bt CDC2721121, but a ~70% decrease in ATG7 levels upon infection with serum-opsonized pathogen, relative to uninfected monocytes (Figure 6A, light gray), suggesting that unopsonized pathogen may preferentially activate autophagosome formation. </plain></SENT>
<SENT sid="361" pm="."><plain>We also observed a ~5-fold increase in MARCKS transcript levels in THP-1 cells infected with unopsonized Bt CDC2721121, whereas there was very little change in MARCKS levels in cells infected with opsonized bacteria (Figure 6A, dark gray). </plain></SENT>
<SENT sid="362" pm="."><plain>Based on our previous findings that MARCKS function was at least partially regulated by PKC-η (Figure 3B), we also examined a putative role for PKC-η in the regulation of MARCKS and ATG7 gene transcription. </plain></SENT>
<SENT sid="363" pm="."><plain>We found that both MARCKS and ATG7 transcript levels were reduced ~2- and ~5-fold, respectively, in cells depleted of PKC-η, compared to control siRNA-treated cells (CTL) upon infection with unopsonized Bt CDC2721121 (Figure 6B). </plain></SENT>
</text></p><SecTag type="FIG"><fig id="F6" position="float"><label>Figure 6</label><caption><p><text><SENT sid="364" pm="."><plain>Downregulation of PKC-η gene expression results in reduced cytoplasmic Burkholderia load and autophagy initiation. (A) A549 cells were infected with unopsonized or serum-coated Bt CDC2721121 (opson Bt) at MOI 50. </plain></SENT>
<SENT sid="365" pm="."><plain>Total RNA was isolated 5 h post infection, and transcript levels of ATG7 and MARCKS were quantified in infected vs. uninfected cells. </plain></SENT>
<SENT sid="366" pm="."><plain>The average and standard deviation from three independent experiments are shown. </plain></SENT>
<SENT sid="367" pm="."><plain>The “*” denotes statistical significance (p &lt; 0.05) for RNA expression in infected host cells compared to uninfected samples. (B) A549 cells were treated with 20 nM siRNA targeting PKC-η or control siRNA (siR-CTL) for 72 h and then infected with unopsonized Bt CDC2721121 at MOI 50. </plain></SENT>
<SENT sid="368" pm="."><plain>Total RNA was isolated 18 h post infection and changes in gene expression profiles of PKC-η, MARCKS, and ATG7 were quantified relative to uninfected cells. </plain></SENT>
<SENT sid="369" pm="."><plain>The average and standard deviation from three independent experiments are shown. </plain></SENT>
<SENT sid="370" pm="."><plain>The “*” denotes statistical significance (p &lt; 0.05) for RNA expression in samples treated with siR-PKC-η compared to their cognate samples treated with control siRNA. (C) A549 cells stably expressing RFP-LC3B were infected with unopsonized Bt CDC2721121 at MOI 50 for 6 h or treated with 0.5 μM rapamycin and analyzed by fluorescent microscopy to image LC3-positive autophagosomes. </plain></SENT>
<SENT sid="371" pm="."><plain>Scale bar, 10 μm. (D,E) Quantifying autophagosomes and cytoplasmic Bt CDC2721121 in lung epithelial cells with imaging flow cytometry. </plain></SENT>
<SENT sid="372" pm="."><plain>A549-RFP-LC3B cells were treated with 20 nM siRNA against PKC-η or non-targeting siRNA (siR-CTL) for 72 h prior to infection with FITC-labeled Bt CDC2721121 at MOI 50. </plain></SENT>
<SENT sid="373" pm="."><plain>No drug or 10 μM rapamycin was added 3 h before bacterial infection for controls. </plain></SENT>
<SENT sid="374" pm="."><plain>Cells were treated with 250 μg/ml kanamycin after 2 h of infection and collected 6 h post-infection for analysis. </plain></SENT>
<SENT sid="375" pm="."><plain>Cells were fixed with 3% paraformaldehyde (pH 6), washed, and then analyzed by Amnis ImageStreamX. </plain></SENT>
<SENT sid="376" pm="."><plain>The average number of RFP-LC3 spots was determined by the ratio of total RPF-positive puncta to the number of analyzed single cells. </plain></SENT>
<SENT sid="377" pm="."><plain>The average number of cytoplasmic bacteria per cell was determined by counting the FITC-positive spots in the green channel and not spots in the red channel divided by the total number of analyzed single cells. </plain></SENT>
<SENT sid="378" pm="."><plain>The average mean and standard deviation represent statistical analysis of 800 fluorescent positive cells per sample. </plain></SENT>
<SENT sid="379" pm="."><plain>The “*” denotes statistical significance (p &lt; 0.05) for the number of cytoplasmic Burkholderia in cells depleted of PKC-η compared to untreated control cells (CTL). </plain></SENT>
</text></p></caption><graphic xlink:href="fcimb-07-00231-g0006"/></fig></SecTag><p><text><SENT sid="380" pm="."><plain>To investigate whether PKC-η may be linked to activation of host macroautophagy in response to B. thailandensis infection, we monitored autophagosome formation in A549 cells that stably expressed a RFP-tagged fusion to the key autophagy protein LC3/ATG8. </plain></SENT>
<SENT sid="381" pm="."><plain>We observed formation of RFP-LC3-labeled autophagosome vesicles 6 h after infection with unopsonized Bt CDC2721121, similar to treatment with rapamycin, a potent inducer of autophagy flux (Figure 6C). </plain></SENT>
<SENT sid="382" pm="."><plain>The average number of RFP-LC3-associated autophagosome vesicles in A549 cells increased &gt;3-fold in infected compared to uninfected cells (Figure 6D). </plain></SENT>
<SENT sid="383" pm="."><plain>We observed that siRNA depletion of PKC-η did not significantly change the number of RFP-LC3-labeled vesicles in infected cells, compared to the untreated (CTL), rapamycin-treated, or siR-CTL-treated controls (Figure 6D). </plain></SENT>
<SENT sid="384" pm="."><plain>However, we did observe a &gt;75% decrease in intracellular cytoplasmic pathogen that was not associated with RFP-LC3-labeled autophagosome vesicles in PKC-η-depleted A549 cells, compared to untreated (CTL) and siR-CTL treated cells (Figure 6E). </plain></SENT>
<SENT sid="385" pm="."><plain>Taken together, these results suggest that upon infection with unopsonized Burkholderia, PKC-η functions in phagocytic pathways that facilitate bacterial escape into the cytoplasm, which in turn activates host macroautophagy. </plain></SENT>
<SENT sid="386" pm="."><plain>Here, we demonstrate that inhibition of PKC-η function reduces the events of intracellular bacterial escape into the cytoplasm using the autophagosome flux activation as a reporter marker. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="DISCUSS"><sec sec-type="discussion" id="s4"><title><text><SENT sid="387" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="388" pm="."><plain>Intracellular pathogens exploit different virulence mechanisms and multiple host factors for efficient invasion, replication, and spread during infection (Hong-Geller and Micheva-Viteva, 2010; Micheva-Viteva et al., 2013; Li et al., 2016). </plain></SENT>
<SENT sid="389" pm="."><plain>We have performed a RNAi screen and identified 35 genes from the human kinome that play an essential role in the infection of B. thailandensis, a close relative of the naturally multidrug-resistant intracellular biothreat pathogen, B. pseudomallei. </plain></SENT>
<SENT sid="390" pm="."><plain>In this study, we have focused on the role of the novel DAG-dependent, Ca2+-independent PKC-η isoform in promoting intracellular survival of Burkholderia in host cells. </plain></SENT>
<SENT sid="391" pm="."><plain>The PKC family consists of at least 10 isoforms classified as conventional, novel, and atypical, depending on the requirement for DAG and Ca2+ for activation. </plain></SENT>
<SENT sid="392" pm="."><plain>Atypical DAG- and Ca2+-independent PKC isoforms (e.g., PKC- ζ) have also previously been implicated in phagosomal escape and intracellular survival of Listeria and Plasmodium sporozoites, suggesting that Ca2+-independent novel and atypical PKC isoforms can mediate intracellular pathogen infection (Prudencio et al., 2008; Jiwani et al., 2012). </plain></SENT>
<SENT sid="393" pm="."><plain>Conventional DAG- and Ca2+-dependent PKC isoforms (e.g., PKC-α) regulate actin cytoskeleton dynamics and antimicrobial immune responses, but were not identified in our screen. </plain></SENT>
<SENT sid="394" pm="."><plain>We had further observed that a dominant-negative variant of PKC-α did not significantly affect host cell survival upon B. thailandensis infection. </plain></SENT>
<SENT sid="395" pm="."><plain>Specific roles for PKC isoforms in CD40 signaling and macrophage infection by Leishmania major have been reported (Sudan et al., 2012). </plain></SENT>
<SENT sid="396" pm="."><plain>Infection of macrophages with L. major was found to enhance PKCδ/ζ/λ–dependent activation of ERK1/2 phosphorylation and Leishmania growth, but impair the functions of PKCα/β/ε responsible for p38MAPK phosphorylation and parasite killing, thus defining differential roles for PKC isoforms in immune homeostasis. </plain></SENT>
</text></p><p><text><SENT sid="397" pm="."><plain>This study links pathogen opsonization with the divergent functions of PKC isoforms. </plain></SENT>
<SENT sid="398" pm="."><plain>Our results show that infection with unopsonized B. thailandensis specifically activates PKC-η regulation of MARCKS function on both transcriptional (expression) and post-transcriptional (phosphorylation) levels to enable pathogen survival within the host. </plain></SENT>
<SENT sid="399" pm="."><plain>We observed that inhibition of PKC-η or MARCKS function by siRNA or functional mutant expression reduced the efficiency of Bt CDC2721121 infection in A549 cells. </plain></SENT>
<SENT sid="400" pm="."><plain>Infection with Y. enterocolitica also led to an increase in MARCKS phosphorylation, suggesting that multiple Gram-negative pathogens can activate the PKC-η/MARCKS pathway during infection. </plain></SENT>
<SENT sid="401" pm="."><plain>MARCKS, a phosphorylation target of PKC, has itself been previously linked to membrane trafficking and actin dynamics. </plain></SENT>
<SENT sid="402" pm="."><plain>Receptor-dependent PKC stimulation regulates trafficking of MARCKS between the plasma membrane, LAMP-1–positive lysosomes (Allen and Aderem, 1995a), and mucin granules (Li et al., 2001). </plain></SENT>
<SENT sid="403" pm="."><plain>Formation of F-actin-rich lamellipodia is dependent on the dephosphorylation and translocation of MARCKS to lipid rafts, causing the recruitment of β-actin to membrane microdomains (Yamaguchi et al., 2009). </plain></SENT>
<SENT sid="404" pm="."><plain>Moreover, a 24 aa peptide derived from the N-terminus of MARCKS was shown to block mucus secretion in a mouse model of asthma, further implicating MARCKS function in actin-mediated secretion (Singer et al., 2004). </plain></SENT>
</text></p><p><text><SENT sid="405" pm="."><plain>Host cell surface receptors, such as MR or FcR, can mediate bacterial uptake via recognition of mannan or antibody opsonins, respectively, on the pathogen cell surface. </plain></SENT>
<SENT sid="406" pm="."><plain>Interestingly, macrophages and fibroblasts isolated from MARCKS-knockout mouse embryos exhibited a decrease in only the MR-mediated uptake of zymosan-coated particles compared to wild type cells, thus linking MR and MARCKS functions in phagocytosis (Underhill et al., 1998; Carballo et al., 1999). </plain></SENT>
<SENT sid="407" pm="."><plain>We find that either saturation of host mannose receptors with mannan or coating of pathogen with anti-sera to block surface interactions and re-direct phagocytic receptor usage leads to a decrease in the replication index of B. thailandensis in A549 cells, suggesting that MR at least partly mediates the uptake and intracellular replication of unopsonized B. thailandensis. </plain></SENT>
<SENT sid="408" pm="."><plain>We also demonstrate that PKC-η is required for the intracellular survival of unopsonized B. thailandensis through the MR-MARCKS pathway. </plain></SENT>
</text></p><p><text><SENT sid="409" pm="."><plain>The results presented here further enhance our understanding of the molecular machinery that regulates phagocytosis (Figure 7). </plain></SENT>
<SENT sid="410" pm="."><plain>It has been previously demonstrated that the PKC isoforms required for phagocytosis appear to be different in monocytes and mature macrophages. </plain></SENT>
<SENT sid="411" pm="."><plain>In monocytes FcγRI stimulation was found to increase PKC activity corresponding to the membrane translocation of the Ca 2+-independent PKC isoforms δ, ε, and ζ while FcγRI stimulation in monocyte-differentiated macrophages involved PKC activity that corresponded to the membrane translocation of the PKC isoforms α, β, and γ (Melendez et al., 1999). </plain></SENT>
<SENT sid="412" pm="."><plain>To date no particular role has been assigned to the novel isoform PKC-η in FcγRI signaling. </plain></SENT>
<SENT sid="413" pm="."><plain>We observed that infection of undifferentiated monocytic THP-1 cells with bacteria coated with anti-B. thailandensis serum resulted in reduced expression of ATG7 and MARCKS, genes we found to be at least partially regulated by the Ca2+-independent PKC-η (Figure 6). </plain></SENT>
<SENT sid="414" pm="."><plain>Our data suggest that this novel isoform has a stronger effect on phagocytic pathways initiated by receptors recognizing pathogen associated molecular patterns in contrast to phagocytosis stimulated by FcγR intearction with IgG opsonized bacteria. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="F7" position="float"><label>Figure 7</label><caption><p><text><SENT sid="415" pm="."><plain>Coating of bacteria with opsonin determines receptor usage and the involvement of protein kinase C (PKC) isoforms in the regulation of phagocytosis-associated cell responses. </plain></SENT>
<SENT sid="416" pm="."><plain>Immunoglobulin G-opsonized bacteria triggers FcγRs-mediated phagocytosis engaging classical PKC isoform signaling pathways leading to pro-inflammatory cell responses, including the respiratory burst leading to efficient killing of bacteria within the lysosomes (Breton and Descoteaux, 2000; Dekker et al., 2000; Sudan et al., 2012). </plain></SENT>
<SENT sid="417" pm="."><plain>Interaction of bacterial glycoproteins with the host cell mannose receptor C-type 1, MRC1, stimulates signaling pathways regulated by the Ca2+-independent PKC isoforms resulting in escape of bacteria from the phagosome into the cytosol. </plain></SENT>
<SENT sid="418" pm="."><plain>Our hypothesis is that PKC inhibitors with selectivity to the novel, Ca2+-independent isoforms have the potential to act as host-directed antimicrobials blocking pathogen escape from phagosome destruction. </plain></SENT>
</text></p></caption><graphic xlink:href="fcimb-07-00231-g0007"/></fig></SecTag><p><text><SENT sid="419" pm="."><plain>In response to pathogen invasion, the host will attempt to restrict intracellular bacterial proliferation by mounting defense mechanisms such as macroautophagy (Romao et al., 2013; Munz, 2014), a process by which cytoplasmic constituents and dysfunctional organelles are recycled in eukaryotic cells (Choy and Roy, 2013; Pareja and Colombo, 2013). </plain></SENT>
<SENT sid="420" pm="."><plain>While autophagy can effectively inhibit intracellular survival of some bacteria (Gutierrez et al., 2004; Nakagawa et al., 2004), Burkholderia species have been shown to subvert this host defense mechanism to establish persistent infection (Colombo et al., 2006; Ogawa and Sasakawa, 2006; Rodrigues et al., 2007). </plain></SENT>
<SENT sid="421" pm="."><plain>Induction of autophagy in murine macrophages can suppress the intracellular survival of pathogenic B. pseudomallei, which in turn, induces the expression of the Type 3 secretion system (T3SS) effector BopA to evade autophagy (Cullinane et al., 2008). </plain></SENT>
<SENT sid="422" pm="."><plain>We observed that expression of ATG7, a mediator of autophagy, is upregulated upon infection with unopsonized B. thailandensis, suggesting that uptake of unopsonized pathogen can lead to phagosomal escape that triggers autophagy. </plain></SENT>
<SENT sid="423" pm="."><plain>Furthermore, siRNA-mediated depletion of PKC-η significantly inhibited ATG7 gene expression levels. </plain></SENT>
<SENT sid="424" pm="."><plain>Finally, our finding that the counts of B. thailandensis not associated with phagosomes was reduced upon PKC-η depletion, whereas phagosome vesicle formation remained unchanged, suggests that PKC-η plays an indirect role in the activation of autophagosome flux, likely by facilitating phagocytic pathways that promote Burkholderia escape into the cytoplasm. </plain></SENT>
</text></p><p><text><SENT sid="425" pm="."><plain>All together, our results support a model in which PKC-η/MARCKS signaling can promote intracellular survival of unopsonized B. thailandensis, at least partly through activation of MR. </plain></SENT>
<SENT sid="426" pm="."><plain>Isoform-specific, PKC-targeted immunotherapy based on in vivo gene silencing has been reported to protect susceptible BALB/c mice from L. major infection (Sudan et al., 2012). </plain></SENT>
<SENT sid="427" pm="."><plain>Highly specific small molecule inhibitors against the novel PKC-η/ζ/ε isoforms, with ~100-fold selectivity over the conventional PKC α/β isoforms, have been identified (van Eis et al., 2011) and could be tested as potential modulators of cellular innate defense against intracellular pathogens. </plain></SENT>
<SENT sid="428" pm="."><plain>Thus, small molecule inhibitors with selectivity to the novel PKC isoform- group may have the potential to act as host-directed antimicrobials blocking pathogen escape from host-mediated destruction. </plain></SENT>
<SENT sid="429" pm="."><plain>Such agents may also contribute to the reduction of antimicrobial resistance to conventional antibiotics (Czyz et al., 2014). </plain></SENT>
</text></p></sec></SecTag><SecTag type="AUTH_CONT"><sec id="s5"><title><text><SENT sid="430" pm="."><plain>Author contributions </plain></SENT>
</text></title><p><text><SENT sid="431" pm="."><plain>Conceived and designed the experiments: SM and EH. </plain></SENT>
<SENT sid="432" pm="."><plain>Performed the experiments: SM, YS, KG, and TW. </plain></SENT>
<SENT sid="433" pm="."><plain>Analyzed the data: SM and EH. </plain></SENT>
<SENT sid="434" pm="."><plain>Wrote the paper: SM and EH. </plain></SENT>
</text></p><sec><title><text><SENT sid="435" pm="."><plain>Conflict of interest statement </plain></SENT>
</text></title><p><text><SENT sid="436" pm="."><plain>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. </plain></SENT>
</text></p></sec></sec></SecTag></body><back><SecTag type="ACK_FUND"><ack><p><text4fund><text><SENT sid="437" pm="."><plain>We thank Dr. Mary Burtnick (University of Southern Alabama) for the B. thailandensis DW503 strain and the BHR4-GFP plasmid. </plain></SENT>
<SENT sid="438" pm="."><plain>We also thank Dr. Kristy Nowak-Lovato and Hongzhao Tian for technical assistance and Dr. Paul Brett, (University of Southern Alabama) for the rabbit anti-serum to B. thailandensis. </plain></SENT>
</text></text4fund></p></ack></SecTag><fn-group><SecTag type="ACK_FUND"><fn fn-type="financial-disclosure"><p><text4fund><text><SENT sid="439" pm="."><plain>Funding. This work was funded by a grant to EH (CBS.MEDBIO.02.10.LA.016) from the Defense Threat Reduction Agency (DTRA) of the Department of Defense (DoD). </plain></SENT>
</text></text4fund></p></fn></SecTag></fn-group><SecTag type="SUPPL"><sec sec-type="supplementary-material" id="s6"><title>Supplementary material</title><p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="http://journal.frontiersin.org/article/10.3389/fcimb.2017.00231/full#supplementary-material">http://journal.frontiersin.org/article/10.3389/fcimb.2017.00231/full#supplementary-material</ext-link></p><supplementary-material content-type="local-data" id="SM1"><media xlink:href="DataSheet1.DOCX"><caption><p><text><SENT sid="440" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material></sec></SecTag><SecTag type="REF"><ref-list><title>References</title><ref id="B1"><text><SENT sid="441" pm="."><plain>AllenL. </plain></SENT>
<SENT sid="442" pm="."><plain>H.AderemA. (1995a). Protein kinase C regulates MARCKS cycling between the plasma membrane and lysosomes in fibroblasts. EMBO J. 14, 1109–1121. <?supplied-pmid 7720702?>7720702 </plain></SENT>
</text></ref><ref id="B2"><text><SENT sid="443" pm="."><plain>AllenL. </plain></SENT>
<SENT sid="444" pm="."><plain>H.AderemA. (1995b). A role for MARCKS, the alpha isozyme of protein kinase C and myosin I in zymosan phagocytosis by macrophages. J. Exp. </plain></SENT>
<SENT sid="446" pm="."><plain>Med. 182, 829–840. 10.1084/jem.182.3.829<?supplied-pmid 7650489?>7650489 </plain></SENT>
</text></ref><ref id="B3"><text><SENT sid="447" pm="."><plain>Astarie-DequeckerC.N'DiayeE.Le CabecV.RittigM.PrandiJ.Maridonneau-PariniI. (1999). The mannose receptor mediates uptake of pathogenic and nonpathogenic mycobacteria and bypasses bactericidal responses in human macrophages. Infect. </plain></SENT>
<SENT sid="448" pm="."><plain>Immun. 67, 469–477.9916047 </plain></SENT>
</text></ref><ref id="B4"><text><SENT sid="449" pm="."><plain>BenoitT. </plain></SENT>
<SENT sid="450" pm="."><plain>J.BlaneyD. </plain></SENT>
<SENT sid="451" pm="."><plain>D.DokerT. </plain></SENT>
<SENT sid="452" pm="."><plain>J.GeeJ. </plain></SENT>
<SENT sid="453" pm="."><plain>E.ElrodM. </plain></SENT>
<SENT sid="454" pm="."><plain>G.WalkeH. </plain></SENT>
<SENT sid="455" pm="."><plain>T.. </plain></SENT>
<SENT sid="456" pm="."><plain>(2015). A review of melioidosis cases in the Americas. Am. </plain></SENT>
<SENT sid="457" pm="."><plain>J. </plain></SENT>
<SENT sid="458" pm="."><plain>Trop. </plain></SENT>
<SENT sid="459" pm="."><plain>Med. </plain></SENT>
<SENT sid="460" pm="."><plain>Hyg. 93, 1134–1139. 10.4269/ajtmh.15-0405<?supplied-pmid 26458779?>26458779 </plain></SENT>
</text></ref><ref id="B5"><text><SENT sid="461" pm="."><plain>BretonA.DescoteauxA. (2000). Protein kinase C-alpha participates in FcgammaR-mediated phagocytosis in macrophages. Biochem. </plain></SENT>
<SENT sid="462" pm="."><plain>Biophys. </plain></SENT>
<SENT sid="463" pm="."><plain>Res. </plain></SENT>
<SENT sid="464" pm="."><plain>Commun. 276, 472–476. 10.1006/bbrc.2000.3511<?supplied-pmid 11027499?>11027499 </plain></SENT>
</text></ref><ref id="B6"><text><SENT sid="465" pm="."><plain>BurtnickM.BoltonA.BrettP.WatanabeD.WoodsD. (2001). Identification of the acid phosphatase (acpA) gene homologues in pathogenic and non-pathogenic Burkholderia spp. facilitates TnphoA mutagenesis. Microbiology 147, 111–120. 10.1099/00221287-147-1-111<?supplied-pmid 11160805?>11160805 </plain></SENT>
</text></ref><ref id="B7"><text><SENT sid="466" pm="."><plain>BurtnickM. </plain></SENT>
<SENT sid="467" pm="."><plain>N.BrettP. </plain></SENT>
<SENT sid="468" pm="."><plain>J.HardingS. </plain></SENT>
<SENT sid="469" pm="."><plain>V.NgugiS. </plain></SENT>
<SENT sid="470" pm="."><plain>A.RibotW. </plain></SENT>
<SENT sid="471" pm="."><plain>J.DeshazerD.. </plain></SENT>
<SENT sid="472" pm="."><plain>(2011). The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei. Infect. </plain></SENT>
<SENT sid="473" pm="."><plain>Immun. 79, 1512–1525. 10.1128/IAI.01218-10<?supplied-pmid 21300775?>21300775 </plain></SENT>
</text></ref><ref id="B8"><text><SENT sid="474" pm="."><plain>BurtnickM. </plain></SENT>
<SENT sid="475" pm="."><plain>N.BrettP. </plain></SENT>
<SENT sid="476" pm="."><plain>J.NairV.WarawaJ. </plain></SENT>
<SENT sid="477" pm="."><plain>M.WoodsD. </plain></SENT>
<SENT sid="478" pm="."><plain>E.GherardiniF. </plain></SENT>
<SENT sid="479" pm="."><plain>C. (2008). Burkholderia pseudomallei type III secretion system mutants exhibit delayed vacuolar escape phenotypes in RAW 264.7 murine macrophages. Infect. </plain></SENT>
<SENT sid="480" pm="."><plain>Immun. 76, 2991–3000. 10.1128/IAI.00263-08<?supplied-pmid 18443088?>18443088 </plain></SENT>
</text></ref><ref id="B9"><text><SENT sid="481" pm="."><plain>BurtnickM. </plain></SENT>
<SENT sid="482" pm="."><plain>N.DeShazerD.NairV.GherardiniF. </plain></SENT>
<SENT sid="483" pm="."><plain>C.BrettP. </plain></SENT>
<SENT sid="484" pm="."><plain>J. (2009). Burkholderia mallei cluster 1 type VI secretion mutants exhibit growth and actin polymerization defects in RAW 264.7 murine macrophages. Infect. </plain></SENT>
<SENT sid="485" pm="."><plain>Immun. 78, 88–99. 10.1128/IAI.00985-09<?supplied-pmid 19884331?>19884331 </plain></SENT>
</text></ref><ref id="B10"><text><SENT sid="486" pm="."><plain>CarballoE.PitterleD.StumpoD.SperlingR.BlackshearP. (1999). Phagocytic and macropinocytic activity in MARCKS-deficient macrophages and fibroblasts. Am. </plain></SENT>
<SENT sid="487" pm="."><plain>J. </plain></SENT>
<SENT sid="488" pm="."><plain>Physiol. 277, C163–C173. <?supplied-pmid 10409119?>10409119 </plain></SENT>
</text></ref><ref id="B11"><text><SENT sid="489" pm="."><plain>ChaplineC. </plain></SENT>
<SENT sid="490" pm="."><plain>C. </plain></SENT>
<SENT sid="491" pm="."><plain>J.TobinH.HulmesJ.CrabbJ.JakenS. (1998). A major, transformation-sensitive PKC-binding protein is also a PKC substrate involved in cytoskeletal remodeling. J. Biol. </plain></SENT>
<SENT sid="493" pm="."><plain>Chem. 273, 19482–19489. 10.1074/jbc.273.31.19482<?supplied-pmid 9677369?>9677369 </plain></SENT>
</text></ref><ref id="B12"><text><SENT sid="494" pm="."><plain>CharoensapJ.UtaisincharoenP.EngeringA.SirisinhaS. (2009). Differential intracellular fate of Burkholderia pseudomallei 844 and Burkholderia thailandensis UE5 in human monocyte-derived dendritic cells and macrophages. BMC Immunol. 10:20. 10.1186/1471-2172-10-20<?supplied-pmid 19397822?>19397822 </plain></SENT>
</text></ref><ref id="B13"><text><SENT sid="495" pm="."><plain>ChinC.MonackD.NathanS. (2010). Genome wide transcriptome profiling of a murine acute melioidosis model reveals insights into how Burkholderia psuedomallei overcomes host innate immunity. BMC Genomics 11:672. 10.1186/1471-2164-11-672<?supplied-pmid 21110886?>21110886 </plain></SENT>
</text></ref><ref id="B14"><text><SENT sid="496" pm="."><plain>ChoyA.RoyC. </plain></SENT>
<SENT sid="497" pm="."><plain>R. (2013). Autophagy and bacterial infection: an evolving arms race. Trends Microbiol. 21, 451–456. 10.1016/j.tim.2013.06.009<?supplied-pmid 23880062?>23880062 </plain></SENT>
</text></ref><ref id="B15"><text><SENT sid="498" pm="."><plain>ColomboM. </plain></SENT>
<SENT sid="499" pm="."><plain>I.GutierrezM. </plain></SENT>
<SENT sid="500" pm="."><plain>G.RomanoP. </plain></SENT>
<SENT sid="501" pm="."><plain>S. (2006). The two faces of autophagy: coxiella and mycobacterium. Autophagy 2, 162–164. 10.4161/auto.2827<?supplied-pmid 16874070?>16874070 </plain></SENT>
</text></ref><ref id="B16"><text><SENT sid="502" pm="."><plain>CullinaneM.GongL.LiX.Lazar-AdlerN.TraT.WolvetangE.. </plain></SENT>
<SENT sid="503" pm="."><plain>(2008). Stimulation of autophagy suppresses the intracellular survival of Burkholderia pseudomallei in mammalian cell lines. Autophagy 4, 744–753. 10.4161/auto.6246<?supplied-pmid 18483470?>18483470 </plain></SENT>
</text></ref><ref id="B17"><text><SENT sid="504" pm="."><plain>CurrieB. </plain></SENT>
<SENT sid="505" pm="."><plain>J. (2015). Melioidosis: evolving concepts in epidemiology, pathogenesis, and treatment. Semin. </plain></SENT>
<SENT sid="506" pm="."><plain>Respir. </plain></SENT>
<SENT sid="507" pm="."><plain>Crit. </plain></SENT>
<SENT sid="508" pm="."><plain>Care Med. 36, 111–125. 10.1055/s-0034-1398389<?supplied-pmid 25643275?>25643275 </plain></SENT>
</text></ref><ref id="B18"><text><SENT sid="509" pm="."><plain>CurrieB. </plain></SENT>
<SENT sid="510" pm="."><plain>J.WardL.ChengA. </plain></SENT>
<SENT sid="511" pm="."><plain>C. (2010). The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl. </plain></SENT>
<SENT sid="512" pm="."><plain>Trop. </plain></SENT>
<SENT sid="513" pm="."><plain>Dis. 4:e900. 10.1371/journal.pntd.0000900<?supplied-pmid 21152057?>21152057 </plain></SENT>
</text></ref><ref id="B19"><text><SENT sid="514" pm="."><plain>CzyzD. </plain></SENT>
<SENT sid="515" pm="."><plain>M.PotluriL. </plain></SENT>
<SENT sid="516" pm="."><plain>P.Jain-GuptaN.RileyS. </plain></SENT>
<SENT sid="517" pm="."><plain>P.MartinezJ. </plain></SENT>
<SENT sid="518" pm="."><plain>J.GabayJ. </plain></SENT>
<SENT sid="519" pm="."><plain>E.. </plain></SENT>
<SENT sid="520" pm="."><plain>(2014). Host-directed antimicrobial drugs with broad-spectrum efficacy against intracellular bacterial pathogens. MBio 5, e01534–e01514. 10.1128/mBio.01534-14<?supplied-pmid 25073644?>25073644 </plain></SENT>
</text></ref><ref id="B20"><text><SENT sid="521" pm="."><plain>DekkerL. </plain></SENT>
<SENT sid="522" pm="."><plain>V.LeitgesM.AltschulerG.MistryN.McDermottA.RoesJ. </plain></SENT>
<SENT sid="523" pm="."><plain>W.. </plain></SENT>
<SENT sid="524" pm="."><plain>(2000). Protein kinase C-beta contributes to NADPH oxidase activation in neutrophils. Biochem J. 347(Pt 1), 285–289. <?supplied-pmid 10727429?>10727429 </plain></SENT>
</text></ref><ref id="B21"><text><SENT sid="525" pm="."><plain>DokerT. </plain></SENT>
<SENT sid="526" pm="."><plain>J.QuinnC. </plain></SENT>
<SENT sid="527" pm="."><plain>L.SalehiE. </plain></SENT>
<SENT sid="528" pm="."><plain>D.SherwoodJ. </plain></SENT>
<SENT sid="529" pm="."><plain>J.BenoitT. </plain></SENT>
<SENT sid="530" pm="."><plain>J.Glass ElrodM.. </plain></SENT>
<SENT sid="531" pm="."><plain>(2014). Fatal Burkholderia pseudomallei infection initially reported as a Bacillus species, Ohio, 2013. Am. </plain></SENT>
<SENT sid="532" pm="."><plain>J. </plain></SENT>
<SENT sid="533" pm="."><plain>Trop. </plain></SENT>
<SENT sid="534" pm="."><plain>Med. </plain></SENT>
<SENT sid="535" pm="."><plain>Hyg. 91, 743–746. 10.4269/ajtmh.14-0172<?supplied-pmid 25092821?>25092821 </plain></SENT>
</text></ref><ref id="B22"><text><SENT sid="536" pm="."><plain>GalyovE. </plain></SENT>
<SENT sid="537" pm="."><plain>E.BrettP. </plain></SENT>
<SENT sid="538" pm="."><plain>J.DeShazerD. (2010). Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis. Annu. </plain></SENT>
<SENT sid="539" pm="."><plain>Rev. </plain></SENT>
<SENT sid="540" pm="."><plain>Microbiol. 64, 495–517. 10.1146/annurev.micro.112408.134030<?supplied-pmid 20528691?>20528691 </plain></SENT>
</text></ref><ref id="B23"><text><SENT sid="541" pm="."><plain>GeierH.CelliJ. (2011). Phagocytic receptors dictate phagosomal escape and intracellular proliferation of Francisella tularensis. </plain></SENT>
<SENT sid="542" pm="."><plain>Infect. </plain></SENT>
<SENT sid="543" pm="."><plain>Immun. 79, 2204–2214. 10.1128/IAI.01382-10<?supplied-pmid 21422184?>21422184 </plain></SENT>
</text></ref><ref id="B24"><text><SENT sid="544" pm="."><plain>GengJ.KlionskyD. </plain></SENT>
<SENT sid="545" pm="."><plain>J. (2008). The Atg8 and Atg12 ubiquitin-like conjugation systems in macroautophagy. </plain></SENT>
<SENT sid="546" pm="."><plain>Protein modifications: beyond the usual suspects' review series. EMBO Rep. 9, 859–864. 10.1038/embor.2008.163<?supplied-pmid 18704115?>18704115 </plain></SENT>
</text></ref><ref id="B25"><text><SENT sid="547" pm="."><plain>GlassM. </plain></SENT>
<SENT sid="548" pm="."><plain>B.GeeJ. </plain></SENT>
<SENT sid="549" pm="."><plain>E.SteigerwaltA. </plain></SENT>
<SENT sid="550" pm="."><plain>G.CavuotiD.BartonT.WilkinsP. </plain></SENT>
<SENT sid="551" pm="."><plain>P.. </plain></SENT>
<SENT sid="552" pm="."><plain>(2006). Pneumonia and septicemia caused by Burkholderia thailandensis in the United States. J. Clin. </plain></SENT>
<SENT sid="554" pm="."><plain>Microbiol. 44, 4601–4604. 10.1128/JCM.01585-06<?supplied-pmid 17050819?>17050819 </plain></SENT>
</text></ref><ref id="B26"><text><SENT sid="555" pm="."><plain>GongL.CullinaneM.TreeratP.RammG.PrescottM.AdlerB.. </plain></SENT>
<SENT sid="556" pm="."><plain>(2011). The Burkholderia pseudomallei type III secretion system and BopA are required for evasion of LC3-associated phagocytosis. PLoS ONE 6:e17852. 10.1371/journal.pone.0017852<?supplied-pmid 21412437?>21412437 </plain></SENT>
</text></ref><ref id="B27"><text><SENT sid="557" pm="."><plain>GutierrezM. </plain></SENT>
<SENT sid="558" pm="."><plain>G.MasterS. </plain></SENT>
<SENT sid="559" pm="."><plain>S.SinghS. </plain></SENT>
<SENT sid="560" pm="."><plain>B.TaylorG. </plain></SENT>
<SENT sid="561" pm="."><plain>A.ColomboM. </plain></SENT>
<SENT sid="562" pm="."><plain>I.DereticV. (2004). Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119, 753–766. 10.1016/j.cell.2004.11.038<?supplied-pmid 15607973?>15607973 </plain></SENT>
</text></ref><ref id="B28"><text><SENT sid="563" pm="."><plain>HaragaA.WestT. </plain></SENT>
<SENT sid="564" pm="."><plain>E.BrittnacherM. </plain></SENT>
<SENT sid="565" pm="."><plain>J.SkerrettS. </plain></SENT>
<SENT sid="566" pm="."><plain>J.MillerS. </plain></SENT>
<SENT sid="567" pm="."><plain>I. (2008). Burkholderia thailandensis as a model system for the study of the virulence-associated type III secretion system of Burkholderia pseudomallei. </plain></SENT>
<SENT sid="568" pm="."><plain>Infect. </plain></SENT>
<SENT sid="569" pm="."><plain>Immun. 76, 5402–5411. 10.1128/IAI.00626-08<?supplied-pmid 18779342?>18779342 </plain></SENT>
</text></ref><ref id="B29"><text><SENT sid="570" pm="."><plain>Hong-GellerE.Micheva-VitevaS. </plain></SENT>
<SENT sid="571" pm="."><plain>N. (2010). Functional gene discovery using RNA interference-based genomic screens to combat pathogen infection. Curr. </plain></SENT>
<SENT sid="572" pm="."><plain>Drug Discov. </plain></SENT>
<SENT sid="573" pm="."><plain>Technol. 7, 86–94. 10.2174/157016310793180657<?supplied-pmid 20836760?>20836760 </plain></SENT>
</text></ref><ref id="B30"><text><SENT sid="574" pm="."><plain>JiwaniS.WangY.DowdG.GianfeliceA. </plain></SENT>
<SENT sid="575" pm="."><plain>P.GavicheriaB.IretonK.. </plain></SENT>
<SENT sid="576" pm="."><plain>(2012). Identification of components of the host type IA phosphoinositide 3-kinase pathway that promote interanlization of Listeria monocytogenes. Infect. </plain></SENT>
<SENT sid="577" pm="."><plain>Immun. 80, 1252–1266. 10.1128/IAI.06082-11<?supplied-pmid 22158742?>22158742 </plain></SENT>
</text></ref><ref id="B31"><text><SENT sid="578" pm="."><plain>JonesA. </plain></SENT>
<SENT sid="579" pm="."><plain>L.BeveridgeT. </plain></SENT>
<SENT sid="580" pm="."><plain>J.WoodsD. </plain></SENT>
<SENT sid="581" pm="."><plain>E. (1996). Intracellular survival of Burkholderia pseudomallei. Infect. </plain></SENT>
<SENT sid="582" pm="."><plain>Immun. 64, 782–790. <?supplied-pmid 8641782?>8641782 </plain></SENT>
</text></ref><ref id="B32"><text><SENT sid="583" pm="."><plain>KimuraS.NodaT.YoshimoriT. (2007). Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy 3, 452–460. 10.4161/auto.4451<?supplied-pmid 17534139?>17534139 </plain></SENT>
</text></ref><ref id="B33"><text><SENT sid="584" pm="."><plain>KuijlC.SavageN. </plain></SENT>
<SENT sid="585" pm="."><plain>D.MarsmanM.TuinA. </plain></SENT>
<SENT sid="586" pm="."><plain>W.JanssenL.NeefjesJ.. </plain></SENT>
<SENT sid="587" pm="."><plain>(2007). Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1. Nature 450, 725–730. 10.1038/nature06345<?supplied-pmid 18046412?>18046412 </plain></SENT>
</text></ref><ref id="B34"><text><SENT sid="588" pm="."><plain>KunyaneeC.KamjumpholW.TaweechaisupapongS.KanthawongS.WongwajanaS.WonggratanacheewinS.. </plain></SENT>
<SENT sid="589" pm="."><plain>(2016). Burkholderia pseudomallei biofilm promotes adhesion, internalization and stimulates proinflammatory cytokines in human epithelial A549 cells. PLoS ONE 11:e0160741. 10.1371/journal.pone.0160741<?supplied-pmid 27529172?>27529172 </plain></SENT>
</text></ref><ref id="B35"><text><SENT sid="590" pm="."><plain>LiN.HennellyS.StubbenC.Micheva-VitevaS.HuB.ShouY.. </plain></SENT>
<SENT sid="591" pm="."><plain>(2016). Functional and structural analysis of a highly-expressed Yersinia pestis small RNA following infection of cultured macrophages. PLoS ONE 11:e0168915. 10.1371/journal.pone.0168915<?supplied-pmid 28030576?>28030576 </plain></SENT>
</text></ref><ref id="B36"><text><SENT sid="592" pm="."><plain>LiY.MartinL.SpizzG.AdlerK. (2001). MARCKS protein is a key molecule regulating mucin secretion by human airway epithelial cells in vitro. J. Biol. </plain></SENT>
<SENT sid="594" pm="."><plain>Chem. 276, 40982–40990. 10.1074/jbc.M105614200<?supplied-pmid 11533058?>11533058 </plain></SENT>
</text></ref><ref id="B37"><text><SENT sid="595" pm="."><plain>LimmathurotsakulD.GoldingN.DanceD. </plain></SENT>
<SENT sid="596" pm="."><plain>A.MessinaJ. </plain></SENT>
<SENT sid="597" pm="."><plain>P.PigottD. </plain></SENT>
<SENT sid="598" pm="."><plain>M.HayS. </plain></SENT>
<SENT sid="599" pm="."><plain>I. (2016). Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat. </plain></SENT>
<SENT sid="600" pm="."><plain>Microbiol. 1, 15008 10.1038/nmicrobiol.2015.8 </plain></SENT>
</text></ref><ref id="B38"><text><SENT sid="601" pm="."><plain>MariappanV.VellasamyK.ThimmaJ.HashimO.VadiveluJ. (2013). Infection of Burkholderia cepacia induces homeostatic response in the host for their prolonged survival: the microarray perspective. PLoS ONE 8:e77418 10.1371/journal.pone.007741824116227 </plain></SENT>
</text></ref><ref id="B39"><text><SENT sid="602" pm="."><plain>MelendezA. </plain></SENT>
<SENT sid="603" pm="."><plain>J.HarnettM. </plain></SENT>
<SENT sid="604" pm="."><plain>M.AllenJ. </plain></SENT>
<SENT sid="605" pm="."><plain>M. (1999). Differentiation-dependent switch in protein kinase C isoenzyme activation by FcgammaRI, the human high-affinity receptor for immunoglobulin G. Immunology 96, 457–464. 10.1046/j.1365-2567.1999.00689.x<?supplied-pmid 10233728?>10233728 </plain></SENT>
</text></ref><ref id="B40"><text><SENT sid="606" pm="."><plain>MemisevicV.ZavaljevskiN.PieperR.RajagopalaS. </plain></SENT>
<SENT sid="607" pm="."><plain>V.KwonK.WallqvistA.. </plain></SENT>
<SENT sid="608" pm="."><plain>(2013). Novel Burkholderia mallei virulence factors linked to specific host-pathogen protein interactions. Mol. </plain></SENT>
<SENT sid="609" pm="."><plain>Cell. </plain></SENT>
<SENT sid="610" pm="."><plain>Proteomics 12, 3036–3051. 10.1074/mcp.M113.029041<?supplied-pmid 23800426?>23800426 </plain></SENT>
</text></ref><ref id="B41"><text><SENT sid="611" pm="."><plain>MemisevicV.ZavaljevskiN.RajagopalaS. </plain></SENT>
<SENT sid="612" pm="."><plain>V.KwonK.PieperR.WallqvistA.. </plain></SENT>
<SENT sid="613" pm="."><plain>(2015). Mining host-pathogen protein interactions to characterize Burkholderia mallei infectivity mechanisms. PLoS Comput. </plain></SENT>
<SENT sid="614" pm="."><plain>Biol. 11:e1004088. 10.1371/journal.pcbi.1004088<?supplied-pmid 25738731?>25738731 </plain></SENT>
</text></ref><ref id="B42"><text><SENT sid="615" pm="."><plain>Micheva-VitevaS.ShouY.Nowak-LovatoK.RectorK.Hong-GellerE. (2013). c-KIT signaling is targeted by pathogenic Yersinia to suppress the host immune response. BMC Microbiol. 13:249. 10.1186/1471-2180-13-249<?supplied-pmid 24206648?>24206648 </plain></SENT>
</text></ref><ref id="B43"><text><SENT sid="616" pm="."><plain>Mochly-RosenD.DasK.GrimesK. </plain></SENT>
<SENT sid="617" pm="."><plain>V. (2012). Protein kinase C, an elusive therapeutic target? Nat. </plain></SENT>
<SENT sid="618" pm="."><plain>Rev. </plain></SENT>
<SENT sid="619" pm="."><plain>Drug Discov. 11, 937–957. 10.1038/nrd3871<?supplied-pmid 23197040?>23197040 </plain></SENT>
</text></ref><ref id="B44"><text><SENT sid="620" pm="."><plain>MooreR. </plain></SENT>
<SENT sid="621" pm="."><plain>A.DeShazerD.ReckseidlerS.WeissmanA.WoodsD. </plain></SENT>
<SENT sid="622" pm="."><plain>E. (1999). Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. </plain></SENT>
<SENT sid="623" pm="."><plain>Antimicrob. </plain></SENT>
<SENT sid="624" pm="."><plain>Agents Chemother. 43, 465–470. <?supplied-pmid 10049252?>10049252 </plain></SENT>
</text></ref><ref id="B45"><text><SENT sid="625" pm="."><plain>MuangsombutV.SuparakS.PumiratP.DamninS.VattanaviboonP.ThongboonkerdV.. </plain></SENT>
<SENT sid="626" pm="."><plain>(2008). Inactivation of Burkholderia pseudomallei bsaQ results in decreased invasion efficiency and delayed escape of bacteria from endocytic vesicles. Arch. </plain></SENT>
<SENT sid="627" pm="."><plain>Microbiol. 190, 623–631. 10.1007/s00203-008-0413-3<?supplied-pmid 18654761?>18654761 </plain></SENT>
</text></ref><ref id="B46"><text><SENT sid="628" pm="."><plain>MunzC. (2014). Regulation of innate immunity by the molecular machinery of macroautophagy. Cell. </plain></SENT>
<SENT sid="629" pm="."><plain>Microbiol. 16, 1627–1636. 10.1111/cmi.12358<?supplied-pmid 25244600?>25244600 </plain></SENT>
</text></ref><ref id="B47"><text><SENT sid="630" pm="."><plain>NakagawaI.AmanoA.MizushimaN.YamamotoA.YamaguchiH.KamimotoT.. </plain></SENT>
<SENT sid="631" pm="."><plain>(2004). Autophagy defends cells against invading group A Streptococcus. Science 306, 1037–1040. 10.1126/science.1103966<?supplied-pmid 15528445?>15528445 </plain></SENT>
</text></ref><ref id="B48"><text><SENT sid="632" pm="."><plain>OgawaM.SasakawaC. (2006). Shigella and autophagy. Autophagy 2, 171–174. 10.4161/auto.2829<?supplied-pmid 16874102?>16874102 </plain></SENT>
</text></ref><ref id="B49"><text><SENT sid="633" pm="."><plain>OwenS. </plain></SENT>
<SENT sid="634" pm="."><plain>J.BatzloffM.ChehrehasaF.MeedeniyaA.CasartY.LogueC.. </plain></SENT>
<SENT sid="635" pm="."><plain>(2009). Nasal-associated lymphoid tissue and olfactory epithelium as portals of entry for Burkholderia pseudomallei in murine melioidosis. J. Infect. </plain></SENT>
<SENT sid="637" pm="."><plain>Dis. 199, 1761–1770. 10.1086/599210<?supplied-pmid 19456230?>19456230 </plain></SENT>
</text></ref><ref id="B50"><text><SENT sid="638" pm="."><plain>ParejaM. </plain></SENT>
<SENT sid="639" pm="."><plain>E.ColomboM. </plain></SENT>
<SENT sid="640" pm="."><plain>I. (2013). Autophagic clearance of bacterial pathogens: molecular recognition of intracellular microorganisms. Front. </plain></SENT>
<SENT sid="641" pm="."><plain>Cell. </plain></SENT>
<SENT sid="642" pm="."><plain>Infect. </plain></SENT>
<SENT sid="643" pm="."><plain>Microbiol. 3:54. 10.3389/fcimb.2013.00054<?supplied-pmid 24137567?>24137567 </plain></SENT>
</text></ref><ref id="B51"><text><SENT sid="644" pm="."><plain>PrudencioM.RodriguesC.HannusM.MartinC.RealE.GoncalvesL.. </plain></SENT>
<SENT sid="645" pm="."><plain>(2008). Kinome-wide RNAi screen implicates at least 5 hepatocyte kinases in Plasmodium sporozoite infection. PLoS Pathog. 4:e1000201. 10.1371/journal.ppat.1000201<?supplied-pmid 18989463?>18989463 </plain></SENT>
</text></ref><ref id="B52"><text><SENT sid="646" pm="."><plain>RodriguesP. </plain></SENT>
<SENT sid="647" pm="."><plain>H.BelangerM.DunnW.Jr.Progulske-FoxA. (2007). Porphyromonas gingivalis and the autophagic pathway: an innate immune interaction? Front. </plain></SENT>
<SENT sid="648" pm="."><plain>Biosci. 13, 178–187. 10.2741/2668<?supplied-pmid 17981536?>17981536 </plain></SENT>
</text></ref><ref id="B53"><text><SENT sid="649" pm="."><plain>RomaoS.GannageM.MunzC. (2013). Checking the garbage bin for problems in the house, or how autophagy assists in antigen presentation to the immune system. Semin. </plain></SENT>
<SENT sid="650" pm="."><plain>Cancer Biol. 23, 391–396. 10.1016/j.semcancer.2013.03.001<?supplied-pmid 23541679?>23541679 </plain></SENT>
</text></ref><ref id="B54"><text><SENT sid="651" pm="."><plain>Rouleux-BonninF.MonsignyM.LegrandA. (1995). Transcriptional expression of mannose receptor gene during differentiation of human macrophages. Biochem. </plain></SENT>
<SENT sid="652" pm="."><plain>Biophys. </plain></SENT>
<SENT sid="653" pm="."><plain>Res. </plain></SENT>
<SENT sid="654" pm="."><plain>Commun. 217, 106–112. 10.1006/bbrc.1995.2751<?supplied-pmid 8526897?>8526897 </plain></SENT>
</text></ref><ref id="B55"><text><SENT sid="655" pm="."><plain>SchweizerH. </plain></SENT>
<SENT sid="656" pm="."><plain>P. (2012). Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis. Future Microbiol. 7, 1389–1399. 10.2217/fmb.12.116<?supplied-pmid 23231488?>23231488 </plain></SENT>
</text></ref><ref id="B56"><text><SENT sid="657" pm="."><plain>SimB. </plain></SENT>
<SENT sid="658" pm="."><plain>M.ChantratitaN.OoiW. </plain></SENT>
<SENT sid="659" pm="."><plain>F.NandiT.TewheyR.TanP.. </plain></SENT>
<SENT sid="660" pm="."><plain>(2010). Genomic acquisition of a capsular polysaccharide virulence cluster by non-pathogenic Burkholderia isolates. Genome Biol. 11:R89. 10.1186/gb-2010-11-8-r89<?supplied-pmid 20799932?>20799932 </plain></SENT>
</text></ref><ref id="B57"><text><SENT sid="661" pm="."><plain>SingerM.MartinL. </plain></SENT>
<SENT sid="662" pm="."><plain>D.VargaftigB. </plain></SENT>
<SENT sid="663" pm="."><plain>B.ParkJ.GruberA. </plain></SENT>
<SENT sid="664" pm="."><plain>D.AdlerK. </plain></SENT>
<SENT sid="665" pm="."><plain>B.. </plain></SENT>
<SENT sid="666" pm="."><plain>(2004). A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma. Nat. </plain></SENT>
<SENT sid="667" pm="."><plain>Med. 10, 193–196. 10.1038/nm983<?supplied-pmid 14716307?>14716307 </plain></SENT>
</text></ref><ref id="B58"><text><SENT sid="668" pm="."><plain>SohJ. </plain></SENT>
<SENT sid="669" pm="."><plain>W.WeinsteinI. </plain></SENT>
<SENT sid="670" pm="."><plain>B. (2003). Roles of specific isoforms of protein kinase C in the transcriptional control of cyclin D1 and related genes. J. Biol. </plain></SENT>
<SENT sid="672" pm="."><plain>Chem. 278, 34709–34716. 10.1074/jbc.M302016200<?supplied-pmid 12794082?>12794082 </plain></SENT>
</text></ref><ref id="B59"><text><SENT sid="673" pm="."><plain>StevensM. </plain></SENT>
<SENT sid="674" pm="."><plain>P.FriebelA.TaylorL. </plain></SENT>
<SENT sid="675" pm="."><plain>A.WoodM. </plain></SENT>
<SENT sid="676" pm="."><plain>W.BrownP. </plain></SENT>
<SENT sid="677" pm="."><plain>J.GalyovE. </plain></SENT>
<SENT sid="678" pm="."><plain>E.. </plain></SENT>
<SENT sid="679" pm="."><plain>(2003). A Burkholderia pseudomallei type III secreted protein, BopE, facilitates bacterial invasion of epithelial cells and exhibits guanine nucleotide exchange factor activity. J. Bacteriol. 185, 4992–4996. 10.1128/JB.185.16.4992-4996.2003<?supplied-pmid 12897019?>12897019 </plain></SENT>
</text></ref><ref id="B60"><text><SENT sid="681" pm="."><plain>SudanR.SrivastavaN.PandeyS.MajumdarS.SahaB. (2012). Reciprocal regulation of protein kinase C isoforms resuls in differential cellular responsiveness. J. Immunol. 188, 2328–2337. 10.4049/jimmunol.1101678<?supplied-pmid 22271653?>22271653 </plain></SENT>
</text></ref><ref id="B61"><text><SENT sid="683" pm="."><plain>SuparakS.KespichayawattanaW.HaqueA.EastonA.DamninS.LertmemongkolchaiG.. </plain></SENT>
<SENT sid="684" pm="."><plain>(2005). Multinucleated giant cell formation and apoptosis in infected host cells is mediated by Burkholderia pseudomallei type III secretion protein BipB. J. Bacteriol. 187, 6556–6560. 10.1128/JB.187.18.6556-6560.2005<?supplied-pmid 16159789?>16159789 </plain></SENT>
</text></ref><ref id="B62"><text><SENT sid="686" pm="."><plain>UlettG.LabrooyJ.CurrieB.BarmesJ.KetheesanN. (2005). A model of immunity to Burkholderia pseudomallei: unique responses following immunization and acute lethal infection. Microb. </plain></SENT>
<SENT sid="687" pm="."><plain>Infect. 7, 1263–1275. 10.1016/j.micinf.2005.04.013<?supplied-pmid 16027024?>16027024 </plain></SENT>
</text></ref><ref id="B63"><text><SENT sid="688" pm="."><plain>UnderhillD.ChenJ.AllenL.AderemA. (1998). MacMARCKS is not essential for phagocytosis in macrophages. J. Biol. </plain></SENT>
<SENT sid="690" pm="."><plain>Chem. 273, 33619–33623. 10.1074/jbc.273.50.336199837946 </plain></SENT>
</text></ref><ref id="B64"><text><SENT sid="691" pm="."><plain>UnderhillD.OzinskyA. (2002). Phagocytosis of microbes: complexity in action. Ann. </plain></SENT>
<SENT sid="692" pm="."><plain>Rev. </plain></SENT>
<SENT sid="693" pm="."><plain>Immunol. 20, 825–852. 10.1146/annurev.immunol.20.103001.114744<?supplied-pmid 11861619?>11861619 </plain></SENT>
</text></ref><ref id="B65"><text><SENT sid="694" pm="."><plain>van EisM.EvenouJ.FloersheimP.GaulC.Cowan-JacobS.MonovichL.. </plain></SENT>
<SENT sid="695" pm="."><plain>(2011). 2,6-naphthyridines as potent and selective inhibitors of the novel protein kinase C isozymes. Bioorg. </plain></SENT>
<SENT sid="696" pm="."><plain>Med. </plain></SENT>
<SENT sid="697" pm="."><plain>Chem. </plain></SENT>
<SENT sid="698" pm="."><plain>Lett. 21, 7367–7372. 10.1016/j.bmcl.2011.10.025<?supplied-pmid 22078216?>22078216 </plain></SENT>
</text></ref><ref id="B66"><text><SENT sid="699" pm="."><plain>WiersingaW. </plain></SENT>
<SENT sid="700" pm="."><plain>J.van der PollT.WhiteN. </plain></SENT>
<SENT sid="701" pm="."><plain>J.DayN. </plain></SENT>
<SENT sid="702" pm="."><plain>P.PeacockS. </plain></SENT>
<SENT sid="703" pm="."><plain>J. (2006). Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat. </plain></SENT>
<SENT sid="704" pm="."><plain>Rev. </plain></SENT>
<SENT sid="705" pm="."><plain>Microbiol. 4, 272–282. 10.1038/nrmicro1385<?supplied-pmid 16541135?>16541135 </plain></SENT>
</text></ref><ref id="B67"><text><SENT sid="706" pm="."><plain>WollenbergA.MommaasM.OppelT.SchottdorfE. </plain></SENT>
<SENT sid="707" pm="."><plain>M.GuntherS.ModererM. (2002). Expression and function of the mannose receptor CD206 on epidermal dendritic cells in inflammatory skin diseases. J. Invest. </plain></SENT>
<SENT sid="709" pm="."><plain>Dermatol. 118, 327–334. 10.1046/j.0022-202x.2001.01665.x<?supplied-pmid 11841552?>11841552 </plain></SENT>
</text></ref><ref id="B68"><text><SENT sid="710" pm="."><plain>WongprompitakP.SirisinhaS.ChaiyarojS. (2009). Differential expression profiles of lung epithelial cells exposed to Burkholderia pseudomallei and Burkholderia thailandensis during the initial phase of infection. Asian Pac. </plain></SENT>
<SENT sid="711" pm="."><plain>J. </plain></SENT>
<SENT sid="712" pm="."><plain>Allergy Immunol. 27, 59–70. <?supplied-pmid 19548631?>19548631 </plain></SENT>
</text></ref><ref id="B69"><text><SENT sid="713" pm="."><plain>YamaguchiH.ShiraishiM.FukamiK.TanabeA.Ikeda-MatsuoY.NaitoY.. </plain></SENT>
<SENT sid="714" pm="."><plain>(2009). MARCKS regulates lamellipodia formation induced by IGF-I via association with PIP2 and beta-actin at membrane microdomains. J. Cell. </plain></SENT>
<SENT sid="716" pm="."><plain>Physiol. 220, 748–755. 10.1002/jcp.21822<?supplied-pmid 19475567?>19475567 </plain></SENT>
</text></ref><ref id="B70"><text><SENT sid="717" pm="."><plain>ZaubermanA.CohenS.MamroudE.FlashnerY.TidharA.BerR.. </plain></SENT>
<SENT sid="718" pm="."><plain>(2006). Interaction of Yersinia pestis with macrophages: limitations in YopJ-dependent apoptosis. Infect. </plain></SENT>
<SENT sid="719" pm="."><plain>Immun. 74, 3239–3250. 10.1128/IAI.00097-06<?supplied-pmid 16714551?>16714551 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
